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Abstract: 
 
 
The minichromosome maintenance (MCM) proteins are essential for the 
initiation and progression of DNA replication. MCMs are believed to 
function as the replicative helicase in archaea and eukaryotes. In the present 
studies, human MCM and archaeal MCM from Methanococcus maripaludis 
were purified from E.coli and assembled as complexes. The six MCMs from 
human co-purified over multiples steps including three chromatographic 
steps when co-expressed in E.coli suggesting that they form a heterohexamer 
complex. Reconstitution of in vitro helicase activity of the human complex 
and individual subunits of M. maripaludis were described. Furthermore the 
effect of phosphorylation on human MCM complex and M. maripaludis 
MCM A were also tested and the effect of phosphorylation was shown to be 
inhibitory on helicase activities. Different reaction conditions were 
monitored on MCM helicase activity and the most interesting was the effect 
of salts on helicase assays which showed that glutamate has a significant 
positive effect while chloride ions inhibit helicase activity. Putative kinases 
were purified from M. maripaludis and Methanocaldococcus jannaschii and 
trials were conducted to assign them a role in regulating the DNA initiation 
process.  
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Chapter 1: Introduction 
 
1.1 DNA replication overview  
 
DNA replication is an essential process in all living organisms. The faithful 
transmission of genetic material requires precise coordination and regulation. 
DNA replication is a biological process that occurs in all living organisms. 
In this process DNA molecules must duplicate accurately and be segregated 
to daughter cells (Albers et al., 2002). This process is initiated at particular 
points in the DNA, known as origins, which are targeted by proteins that 
separate the two strands and initiate DNA synthesis (Berg et al., 2002). 
Origins contain DNA sequences recognized by replication initiator proteins 
for examples DnaA in E. coli and the origin recognition complex in yeast 
(Weigel et al., 1997). These initiator proteins recruit other proteins to 
separate the two strands and initiate replication forks. To dissect this 
multistep process of DNA replication, it is important to find out all the 
proteins involved in this process and the role of each protein in each of these 
steps. There are a number of proteins already known that are involved in this 
process but still there are gaps in our knowledge of all proteins and their 
functions. These proteins are different in the three different domain of life. 
The work of Carl Woese in late 1970s (Woese and Fox, 1977) led to the 
biological classification of life into three domains that divide cellular life 
forms into bacteria, archaea and eukarya (Figure 1.1). The realization that 
living organisms can be divided into three main lineages, led to a quest to 
discover the molecular fundamentals that distinguish them. 
 
1.1.1 Bacterial replication  
 
The replicon hypothesis postulates two basic elements for the initiation of 
replication: the initiator, a trans-acting substance, DnaA protein, and the cis-
acting replicator, which we now call the replication origin, oriC (Jacob and 
Brenner, 1963). The initiator protein DnaA is found in all bacteria analyzed 
so far. The bacterial chromosome typically contains a single origin of 
replication oriC. Binding of DnaA to such an array, origin recognition, is the 
 14 
p 
 
 
 
Figure 1.1 Tree of lif: This illustration of the three domains of life is like a 
family tree. The branches that are very far apart are not very similar. 
Branches that are near each other indicate closely related groups. This figure 
is taken from http://www.greennature.ca. 
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first step in the assembly of a specialized nucleoprotein complex (Echols, 
1990), the initiation complex. Most of our understanding on bacterial 
replication comes from the extensive research on E.coli. DnaA protein binds 
to its five binding sites in oriC as a monomer, introducing a 40o bend at each 
site (Schaper and Messer, 1995). Only DnaA complexed with ATP is active 
in initiation (Sekimizu et al., 1987). ATP-DnaA binds to additional sites, 6-
mer ATP-DnaA boxes with the sequence 5’P-AGATCT or a close match 
(Speck et al., 1999; Speck and Messer, 2001). These sites are predominant in 
the AT-rich region, which is unwound, and subsequently stabilized due to 
specific binding of ATP-DnaA to single-stranded ATP-DnaA boxes. The 
unwound region spans 28 bp without and 44-46 bp with SSB (Single-strand 
binding protein) present (Krause and Messer, 1999). Since single-stranded 
DNA covered with SSB is a poor substrate for DnaB helicase, it has to be 
loaded with the help of DnaA. Two double hexamers of DnaB and the 
helicase loader DnaC, one double hexamer for each replication direction, are 
positioned by DnaA into the loop (Fang et al., 1999; Carr and Kaguni, 2001). 
DnaC leaves the complex immediately after or during loading, accompanied 
by ATP hydrolysis. This activates the helicase activity of DnaB (Wahle et 
al., 1989A, Wahle et al., 1989B). The two DnaB hexamers slide past each 
other in 5’-3’ direction, and expand the bubble to about 65 nucleotides (Fang 
et al., 1999). Now primase can enter the complex and synthesize two leading 
strand primers.  
 
The unwinding of double-stranded origin DNA and the loading of helicase 
into this region are one of the basic reactions in the cell cycle.  
 
1.1.2 Archaeal replication  
 
The status of the archaea as one of the three primary domains emphasizes the 
importance of understanding their molecular fundamentals. Basic DNA 
replication in the archaea is much similar to eukaryal replication. Archaea 
replicate their circular genome from a single DNA replication origin mostly 
as do bacteria, even though they may use eukaryotic-like proteins to do so  
(Myllykallio and Forterre, 2000). 
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All archaeal genomes sequenced to date contain at least one gene with 
homology to both ORC1 (Origin recognition complex subunit 1) and Cdc6 
(Cell Division Cycle 6) (Barry and Bell, 2006). Origin Recognition Complex 
is a multi-subunit DNA binding complex (6 subunits) that binds in all 
eukaryotes in an ATP-dependent manner to origins of replication. The 
subunits of this complex are encoded by the ORC1, ORC2, ORC3, ORC4, 
ORC5 and ORC6 genes. Cdc6 is part of the pre-replicative complex (pre-
RC) and is required for loading Minichromosome Maintenance (Mcm) 
proteins onto the DNA, an essential step in the initiation of DNA synthesis. 
The ORC1/Cdc6 proteins were identified to act as the origin recognition and 
binding proteins in archaea (Lundgren et al., 2004; Robinson et al., 2004). 
Structures show that the C-terminal region of ORC1/Cdc6 contains a 
winged-helix (WH) domain, and sequence alignments show that this is 
conserved throughout archaeal and eukaryotic Cdc6 proteins (Liu et al., 
2000; Singleton et al., 2004). All archaeal genomes sequenced to date have 
at least one Mcm homologue  (Majernik et al., 2004). Archaeal Mcm has 
shown efficient DNA binding and helicase activity in vitro (Kelman et al., 
1999; Chong et al., 2000). For archaea, little is known about Mcm loading. 
There is apparently no homologue of DnaC or Cdt1 (Cyclin dependent 
transcript 1) in archaea, suggesting that the ORC1/Cdc6 proteins may 
perform the functions carried out by ORC, Cdc6, and Cdt1 in eukaryotes. 
Binding of archaeal ORC1/Cdc6 proteins to origins is apparently ATP 
independent (Robinson et al., 2004), despite the fact that they have a 
functional AAA+ domain (Grabowski and Kelman, 2001; Singleton et al., 
2004). ATP hydrolysis by Cdc6 may be important for Mcm loading. The 
GINS (Go, Ichi, Nii, San) complex is essential in yeast and interacts with 
Mcm and CDC45 (Cell Division Cycle 45), which is an essential protein 
required to the initiation of DNA replication (Kubota et al., 2003; Gambus et 
al., 2006). More recently, it was shown that GINS is necessary for the 
inclusion of Mcm in replisome progression complexes, which include 
several replication and checkpoint proteins, (Gambus et al., 2006). An 
archaeal homologue of GINS was also identified, suggesting a role in pairing 
Mcm activity on the leading strand with primase activity on lagging strand 
(Marinsek et  al.,  2006).  Despite our   emerging    understanding of archaeal  
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replication, little is known about its mechanisms of regulation. 
 
1.1.3 Eukaryotic replication 
 
DNA replication in eukaryotes is much more complicated than in bacteria or 
archaea, although there are many similar aspects. Eukaryotic cells can only 
initiate DNA replication at a specific point in the cell cycle. The cell-division 
cycle is the series of events that takes place in a cell leading to its division 
and duplication (replication). In eukaryotes, the budding yeast 
Saccharomyces cerevisiae DNA replication origins have been extensively 
studied and the best characterised eukaryotic origins (Bell and Dutta, 2002).  
 
1.1.3.1 Stepwise assembly of replisome  
 
In budding yeast, replication origins are bound throughout the cell cycle by a 
conserved six-subunit protein complex known as ORC like archeae. ORC 
protein complex is bound at replication origins characterised by the presence 
of ARS (autonomously replicating sequences) throughout the cell cycle, 
allowing replicative proteins access to the ARS (Huberman et al., 1987; 
Fangman and Brewer, 1991). During the G1 -phase of the cell cycle, ORC is 
bound by the Cdc6 protein, which then recruits two additional factors, Cdt1 
and the Mcm helicase, to form the pre-RC (pre-replicative complex) (Diffley 
et al., 1994; Speck et al., 2005; Chen et al., 2007). Assembly of pre-RC takes 
place in late M and early G1 phase when the cyclin dependent kinase (CDK) 
activity is low. The high CDK activity prevents pre-RC assembly by 
phosphorylating components of pre-RC and inhibiting their activities 
(Diffley, 2004). Subsequent to pre-RC assembly, replication initiation is 
promoted by the action of S-CDK (S-phase CDK) and a second protein 
kinase, DDK (Cdc7-Dbf4) (Dutta, and Bell, 1997; Bell and Dutta, 2002). S-
CDK main substrates in yeast are two essential proteins, Sld2 and Sld3, 
(Tanaka et al, 2007; Zegerman, and Diffley, 2007). Phosphorylation of Sld3 
by S-CDK blocks entry into S-phase. The effect of the phosphorylation of 
Sld3 is to generate a binding site for another essential replication factor, 
Dpb11 (Tanaka et al., 2007; Zegerman and Diffley, 2007) that is equivalent 
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to TOPBP1 in human cells. The N-terminal Dpb11 BRCT domain is 
responsible for binding to phosphorylated Sld3. The importance of 
phosphorylation in mediating Dpb11 binding is shown by the fact that fusion 
of non-phosphorylatable Sld3 to Dpb11 produces a protein that is able to 
rescue loss-of-function mutations in both genes and partially bypass the 
requirement for S-CDK activity to initiate S-phase (Zegerman and Diffley, 
2010). Sld3 also associates with another essential replication factor, Cdc45, 
which is likely to be recruited to the pre-RC via its interactions with Mcm 
(Figure 1.2).  
 
The second essential S-CDK substrate in yeast is Sld2 (equivalent to 
RecQL4 in human cells) (Tanaka et al., 2007; Zegerman and Diffley, 2007). 
This protein is phosphorylated on multiple sites by S-CDK, but Thr84 
phosphorylation is crucial for Sld2 function (Masumoto et al., 2002). The 
effect of Thr84 phosphorylation is also to create a binding site for Dpb11, 
via the C-terminal Dpb11 BRCT domains. Sld2 is reportedly (Tanaka et al., 
2007) part of a complex (termed the pre-loading complex or pre-LC) that 
includes Dpb11, the leading strand polymerase Polε and GINS, suggesting 
that the function of Dpb11 in bridging Cdc45–Sld3 with Sld2 is to recruit the 
pre-LC components to the origin to activate the Mcm helicase (Figure 1.2).  
 
Once the replisome is activated, the replication forks move off 
bidirectionally from the origin DNA into the surrounding sequences. ORC 
remains bound at the origin, apparently intact, at least in yeast cells, whereas 
Mcm, Cdc45, GINS and Polε move with the fork (Aparicio et al., 1997; 
Aparicio, et al., 1999; Kanemaki et al., 2003; Takayama, et al., 2003; 
Kanemaki, and Labib, 2006). The remainder of the factors described above 
dissociate from the replisome and in some cases are degraded or excluded 
from the nucleus.  
 
Unlike yeast or bacterial origins, metazoan origins appear to have very low 
ARS activity in general even though some origins show ARS activity 
(Ariizumi et al., 1993; Taira et al., 1994; Berberich et al., 1995). Replication 
initiation   sites    appear to occur   within particular regions of chromosomes 
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Figure 1.2 Model for stepwise replisome assembly in budding yeast: In G1, 
Cdc6 binds to ORC and recruits the Mcm helicase and Cdt1 to form the pre-
RC. Cdc45–Sld3 appears to associate with pre-RC-bound origins in G1. Sld3 
is phosphorylated by S-CDK, allowing it to bind to Dpb11 and recruit the 
pre-LC. The pre-LC contains Dpb11, Sld2, polymerase Pol ε and the GINS. 
Cdc45, Mcm and GINS form a tight complex (CMG) that moves with the 
replication fork. Assembled around a single CMG complex is the multi-
protein replisome progression complex (RPC). The replisome is shown 
moving to the left (indicated by block arrow): Pol ε is shown synthesizing 
the leading strand (MacNeill, 2010). 
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called “initiation zones” in higher eukaryotes (Hamlin et al., 2008). 
 
A cartoon representation comparing the important factors involved in 
replication initiation in the three domain of life is summarized in table 1.1 
 
1.2. Helicases as essential replication factors 
 
Helicases are motor proteins that move directionally along a nucleic acid 
phosphodiester backbone, separating two annealed nucleic acid strands (i.e., 
DNA, RNA, or RNA-DNA hybrid) using energy derived from ATP 
hydrolysis (Gorbalenya et al., 1988). Helicases are present in all domains of 
life and play important roles in DNA replication by unwinding the duplex.  
A crucial step in the initiation of DNA replication involves the loading of 
helicase proteins onto the duplex. In E.coli, DnaC is the protein responsible 
for loading the hexameric DnaB helicase onto the origin bound by DnaA 
(Davey el al., 2002). The final step is the activation of DnaB helicase so that 
the unwinding of the duplex allows entry of the DNA polymerase machinery 
(Leatherwood, 1998; Mariorano and Mechali, 2002). In eukaryotes, Cdc6 
and Cdt1 are responsible for loading of hexameric Mcm proteins onto the 
origin while very little is known about the archaeal loading machinery but 
the replicative helicase, the Mcm complex is conserved within archaea. All 
Mcms share a great deal of homology, particularly in the central domain of 
the protein, which spans nearly 200 amino acids and includes the NTP 
binding and hydrolysis domain (Hall and Matson, 1999). 
  
1.3 The Mcm2-7 complex as a DNA helicase    
 
The Mcm2-7 complex is the main candidate to be the DNA helicase 
associated with replication in archaea and eukarya, although there are still 
certain gaps in our knowledge about the method by which they function. 
Experimental work on Saccharomyces cerevisiae, Schizosaccharomyces 
pombe and Xenopus laevis showed that the Mcms are nuclear proteins 
required for DNA replication (Gibson et al., 1990;  Chen at al., 1992; Maiti 
and Sinha 1992; Kubota et al., 1995). Soon   after the   their   discovery   as a 
 21 
 
 
 
Table 1.1 A cartoon representation of factors involved in DNA replication: 
Summary of important factor that involved in the process of initiation of 
DNA in the three domains of life.  
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nuclear protein in yeast, their homologues were identified in mammalian 
cells (Thommes at al., 1992). It was then hypothesized that Mcms could be a 
component of the replication licensing factor (RLF) activity defined when 
G1 chromatin is licensed to replicate and G2 is barred from this licensing 
process to prevent unscheduled DNA synthesis, which limits DNA 
replication to once per cycle (Blow and Laskey, 1988). This hypothesis was 
confirmed when the Mcm complex was purified from the RLF isolated from 
Xenopus egg extracts (Chong et al., 1995). Later six Mcm proteins were 
identified, given the names of Mcm2-Mcm7 and showed that they were 
conserved in all eukaryotes (Chong et al., 1996; Kearsey et al., 1996). Like 
all other helicases, the Mcm subunits contain a conserved central AAA+ 
motif (discussed in section 1.5.1) and the general structure of the Mcm 
complex resembles other DNA helicases. 
 
It has also been found in Xenopus eggs that if the Mcm complex is 
inactivated then chromosome unwinding during S phase is inhibited (Madine 
at al., 2000). Early data suggested that the Mcms play an important role in 
DNA initiation but more recent studies show that Mcms also play a role in 
replication elongation, transcription, DNA repair and chromatin remodelling 
(Prokhorova and Blow, 2000; Labib et al., 2000; Labib et al., 2001; 
Forsburg, 2004). DNA helicase activity was first identified in the human 
Mcm4/6/7 complex of around 600 KDa containing approximately equal 
amounts of each Mcm suggesting a dimer of trimers. Cross-linking studies 
suggests that this hexamer consisting of two molecules each of Mcm4, 
Mcm6 and Mcm7 (Ishimi, 1997).  
 
It is clear from a variety of experiments in different systems that Mcms 
associate with one another, perhaps forming a variety of complexes with 
differing stoichiometries. A large Mcm protein complex of around 450 – 600 
kDa has been detected in extracts from budding yeast (Lei et al., 1996), 
fission yeast (Adachi et al., 1997), Drosophila (Su et al., 1997), Xenopus 
(Hendrickson et al., 1996; Kubota et al., 1997; Thommes et al., 1997) and 
mammalian  (Kimura et al., 1996; Richter and Knippers, 1997) cell extracts. 
Some studies support the idea that the Mcm2-7 complex represents a hetero-
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hexamer of Mcm proteins, where each Mcm type is present in equal 
stoichiometry. Immunoprecipitation with antibodies to a specific Mcm 
protein in Xenopus extracts precipitates all six Mcm proteins in 
approximately equal amounts (Kubota et al., 1997). 
 
Other reports suggest that Mcm proteins may interact to form more 
heterogeneous complexes, consisting of tetramers or hexamers with different 
compositions (Lei et al., 1996; Su et al., 1997; Thommes et al., 1997). The 
Mcm proteins can be isolated as several stable subassemblies including Mcm 
2/3/4/5/6/7 (hexamer), Mcm 2/4/6/7 (tetramer), Mcm 4/6/7 (trimer) and 
Mcm3/5 (dimer) complexes (Lei et al., 1996; Thommes et al., 1997; Ishimi, 
1997; Holthoff et al., 1998; Sherman and Forsburg, 1998) but no helicase 
activity was detected in these complexes (Davey et al., 2003).  
 
The Mcm2-7 hexamer (Mcm 2/3/4/5/6/7) has been shown recently to 
possess anionic dependent helicase activity in vitro (Bochman and 
Schwacha, 2008). In vitro studies using recombinant Mcm proteins from S. 
pombe indicated that Mcm2 could inhibit the helicase activity of the 
Mcm4/6/7 complex (Ishimi, 1997; Lee and Hurwitz, 2000).  The binding of 
the Mcm3/5 complex to Mcm4/6/7 also inhibits the DNA helicase activity of 
Mcm4/6/7 complex by converting its double trimer structure into a hetero-
tetramer or hetero-pentamer (Sato et al., 2000). So far two different 
complexes are known to play a role in unwinding dsDNA (Kanter et al., 
2008), Mcm4/6/7 (Ishimi et al., 1997; You et al., 1999) and Mcm2-7 
(Bochman et al., 2008). Mcm6 from pea has shown to function as a DNA 
helicase as a single subunit (Tran et al., 2010).  
 
1.4 Phylogenetic analysis of Mcm 
 
The Mcm complex was first discovered in budding yeast as mutants that 
were unable to maintain small chromosome-like structures (Maine et al., 
1984). The complete genome sequence of S. cerevisiae indicates that there 
are six Mcm helicase encoding genes (Kearsey and Labib, 1998) and the 
phylogentic analysis suggested that there are six distinct classes of Mcm 
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proteins ranging from yeast to man (Chong et al., 1996). Identification of 
Mcm proteins in higher eukaryotes initially came from the detection of a 
murine protein related to S. cerevisiae Cdc 46/ Mcm5 (Hennessy, 1991) and 
the isolation of human P1 protein (homologous to Mcm 3) that co-purified 
with DNA polymerase α (Thommes et al., 1992) indicated the presence of 
Mcm in humans whilst the considerable sequence conservation of the family 
has made it easy to identify other higher eukaryotic homologues (Coxon et 
al., 1992; Hu et al., 1993; Sabelli et al., 1996). Higher eukaryotic Mcms have 
also emerged by the characterization of mRNAs or antigens that are 
specifically associated with proliferating cells (Todorov et al., 1994; Feger et 
al., 1995; Starborg et al., 1995; Sykes and Weiser, 1995) or by screening for 
mutants affecting cell proliferation during development in Drosophila 
(Treisman et al., 1995) or Arabidopsis (Springer et al., 1995). Phylogenetic 
comparison of eukaryotic Mcms sequences shows that the six classes of 
Mcm proteins are approximately equally related (Figure 1.3). The tendency 
of Mcm proteins to interact with each other has made it possible in some 
cases to co-purify and characterize proteins in the family (Kubota et al., 
1997; Kimura et al., 1996). Higher eukaryotic Mcms are also present in 
archaea. Although archaea are prokaryotes, their replication machinery and 
the proteins participating in the initiation of DNA replication are more 
similar to those found in eukarya than bacteria (Grabowski and Kelman, 
2003).  
 
1.4.1 Archael Mcm 
 
In all eukaryotes six Mcm proteins are found but this is not true for archaea. 
All archaeal species sequenced to date contain at least one homologue of the 
eukaryotic Mcm2–7 family (reviewed in Kelman and Kelman, 2003; 
Enemark and Joshua-Tor, 2008) and evidence is accumulating that Mcm is 
also the archaeal replicative helicase. Most of the archaea have usually one 
Mcm homologue but the Methanocaldococcus jannaschii and 
Methanococcus maripaludis S2 genomes contains four Mcms (Bult et al., 
1996; Hendrickson et al., 2004), while Methanothermobacter 
thermautotrophicus   has    just    a  single Mcm that forms a double hexamer 
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Figure 1.3 Phylogenetic tree of eukaryotic Mcms assembled using ClustalX: 
This figure was generated using PHYLODENDRON and taken from the 
Forsburg, 2004. Colours correspond to the seven Mcm subfamilies. 
Schizosaccharomyces pombe Mcm: SpMcm; Saccharomyces cerevisiae 
Mcm: ScMcm; Homo sapiens (Human) Mcm: HsMcm; Xenopus laevis 
Mcm: Xmcm; Arabidopsis thaliana Mcm: AtMcm; Drosophila 
melanogaster Mcm: DmMcm. 
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complex and has an ATP-independent DNA-binding activity which can 
distinguish between single- and double- stranded DNA and has 3’-5’ 
helicase activity with the requirement of ATP hydrolysis (Chong et al., 
2000). The first structural information on the archaeal Mcm came from 
electron microscope (EM) reconstructions studies of the Mcm protein from 
the archaeon Methanothermobacter thermautotrophicus (Chong et al., 2000; 
Yu et al., 2002). Furthermore it was suggested that the helicase formed 
heptameric rings and helical filaments (Yu et al., 2002; Chen et al., 2005) 
compared to the initial study where it was shown to form a double hexamer 
structure in solution (Chong et al., 2000) and supported by electron 
microscopy (Gomez-Llorente et al., 2005) and structural studies (Fletcher et 
al., 2003). Subsequent EM studies with the same Mcm protein revealed 
structural polymorphism. It was found that in addition to helical filaments 
and heptameric rings the protein also formed double heptamers, hexamers 
and double hexamers, octamers and open rings (Pape et al., 2003; Gomez-
Llorente et al., 2005; Costa et al., 2006 a,b; Jenkinson et al., 2009). The 
single Mcm from M. thermautotrophicus was the first archaeal Mcm that 
was shown to have DNA binding, ATPase and 3’-5’ helicase activities 
(Kelman et al., 1999; Chong et al., 2000; Shechter et al., 2000). Helicase 
activities were then demonstrated for Mcms from S. solfataricus (Carpentieri 
et al., 2002), Archaeoglobus fulgidus (Grainge et al., 2003) and Aeropyrum 
pemix (Atanassova and Grainge, 2008). A near-full-length Sulfolobus 
solfataricus Mcm hexamer has generated based on the 6-fold symmetry of 
the N-terminal Methanothermobacter thermautotrophicus (Mth) hexamer 
(Brewster et al., 2008). 
 
1.4.2 Eukaryotic Mcms 
 
All eukaryotic Mcm sequences obtained thus far appear to be homologous to 
one or other of the six S. cerevisiae Mcm proteins, suggesting that there were 
six distinct Mcm genes in a primordial eukaryote. Recently, two more 
additional distantly related proteins Mcm8 and Mcm9 (Maiorano et al., 
2005; Maiorano et al., 2006) have been identified, however, these are not 
present in all eukaryotes (Gozuacik et al 2003, Lutzmann et al., 2005). 
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Mcm9 only exists in vertebrates (Maiorano et al., 2006). Mcm8 functions in 
the elongation step of DNA replication as a helicase and stimulates the 
processivity of DNA polymerases at replication sites. Mcm8 does not 
associate with the soluble Mcm2-7 complex and binds chromatin upon 
initiation of DNA synthesis (Maiorano et al., 2005). It has been 
demonstrated that Mcm9 binds to chromatin in an ORC-dependent manner 
and is required for the recruitment of the Mcm2-7 helicase onto chromatin 
(Lutzmann and Mechali, 2008). There has been no direct interaction detected 
between these newly discovered Mcms and the Mcm2-7 helicase family 
(Maiorano et al., 2005; Lutzmann and Mechali, 2008).  
 
Mcm1 and Mcm10 do not belong to this family but are conserved in higher 
eukaryotes. Mcm1 is a transcription factor that may play a role in DNA 
synthesis while Mcm10 appears to be directly required to initiate DNA 
synthesis (Maiorano et al., 2006). 
 
1.5 Biochemical properties of the Mcm proteins 
 
The Mcms belong to a distinct subgroup of the large AAA+ ATPase family 
of proteins, which has many cellular functions (Davey et al., 2002). AAA+ 
ATPases generally form large ATP-dependent complexes. Mcms can be 
divided into three different domains (Figure. 1.4) which are highly 
conserved; an N-terminal domain which contains a Zn-finger motif, a central 
AAA+ (ATPases Associated with various cellular Activities) domain 
containing Walker A and Walker B motifs and a C-terminal domain 
containing a winged helix-turn-helix motif (Jenkinson and Chong, 2006).  
 
1.5.1 The AAA+ domain 
 
The central AAA+ domain can be divided into an α/β subdomain (the 
functional core of the enzyme) and an α subdomain mediating inter-subunit 
contacts. The α/β subdomain contains the Walker A, Walker B and arginine 
finger signature sequence motifs typical of AAA+ ATPases  (Koonin, 1993). 
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Figure 1.4 A schematic representation of the domain structure of Mcms: The 
Mcm cartoon is showing N-terminal domain containing zinc-finger and β-
hairpin, central AAA+ ATPase domain containing Walker A and B motif, β-
α-β insert, PS1BH (pre-sensor 1 beta-hairpin), and a C-terminal domain with 
wHTH (winged-helix-turn-helix) (Jenkinson and Chong, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
Crystal structure of nearly full-length Mcm from Sulfolobus solfactaricus 
has been solved (Breswster et al., 2008).  A systematic classification of 
AAA+ proteins has been carried out and identified a superclade which 
includes the Mcm proteins and is characterised by an insertion in the α/β 
subdomain occurring before the `sensor 1' motif and forming a β-hairpin 
(Iyer et al., 2004). This insertion has been called the pre-sensor 1 β-hairpin 
(PS1BH) and defines the superclade. Point mutation analysis of the 
Sulfolobus solfataricus Mcm (SsoMcm) orthologue demonstrated that this 
insertion has a role in DNA binding and helicase activity (McGeoch et al., 
2005). Within the PS1BH superclade, a number of AAA+ proteins contain 
an additional insertion in the α/β subdomain, disrupting the continuity of 
helix 2 (Iyer et al., 2004). In Mcm proteins, the h2i (helix-2 insert) has been 
proposed to act as a ploughshare separating the two strands during the 
helicase reaction (Chong 2005; Jenkinson and Chong, 2006).  
 
1.5.2 N-terminal domain and the zinc finger 
 
The N-terminal domain of the archeael Mcm has been shown to be important 
in binding to single stranded DNA, protein multimerisation and the 
regulation of helicase activity (Jenkinson and Chong, 2006; Kasiviswanathan 
et al., 2004). The conserved zinc finger motif found in the N-terminal 
domain of the Mcm has shown to be essential for helicase activity 
(Poplawski et al., 2001). The N-terminal domain has also been shown to be 
the site of interaction with the origin binding protein, cdc6, which modulates 
the activity of Mcm (Kasiviswanathan et al., 2005; Haugland et al., 2006). 
Mutation in the conserved loop of the N-terminal domain has no effect on 
DNA binding but caused decreases in ATPase and helicase activities 
(Sakakibara et al., 2008). 
 
The crystal structures of the poorly conserved N-terminal portion of 
Methanothermobacter thermautotrophicus Mcm (N-MthMcm) and 
Sulfolobus solfataricus Mcm (N-SsoMcm) reveal that this region influencesn 
the formation of dodecamers (Figure 1.5 A) and hexamers (Fletcher et al., 
2003; Liu et al., 2008). The monomeric fold and the assembled hexamer 
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structures of the N-SsoMcm and N-MthMcm are highly conserved (Fletcher 
et al., 2003; Liu et al., 2008). A β-hairpin structure present in the N domain 
of the both Mcm proteins protrudes into the central hexameric channel to 
form the narrowest point within the channel, possibly for interacting with 
DNA at a certain stage of Mcm function (Fletcher et al., 2003; McGeoch et 
al., 2005). 
 
1.5.3 C-terminal domain  
 
The last 100 amino acids of the MthMcm protein include a predicted helix–
turn–helix motif (HTH), a fold typical of DNA interacting domains (Aravind 
and Koonin, 1999). The HTH motif appears to be present in other archaeal 
Mcm sequences but not in eukaryotic proteins. A deletion mutant of the 
MthMcm protein lacking the C-terminal domain (Δ597) showed increased 
dsDNA-stimulated ATP hydrolysis and increased the affinity of the mutant 
complex for ssDNA and dsDNA but lower helicase activity, observed by 
steady state fluorescence (Jenkinson and Chong, 2006). FRET (fluorescence 
resonance energy transfer) experiments on the SsoMcm also suggested a 
DNA-induced conformational change involving the C-terminal domain 
(McGeoch et al., 2005). These observations indicate a possible role for the 
C-terminal domain in coupling the ATP hydrolysis and DNA spooling 
motion necessary for the helicase activity. 
 
1.5.4 Hairpins  
 
There are three beta (β) hairpin structures located in the C terminal half of 
Mcm (Figure 1.5 B). The presensor 1 beta hairpin (PS1BH), which is 
predicted to protrude into the central channel of the complex at the 
intersection with the side channel (Brewster et al., 2008) has been shown to 
be essential for  helicase activity (McGeoch et al., 2005). An insert in helix 2 
that forms another β-hairpin structure between the Walker A and B motifs is 
unique to the Mcms and was predicted to play a role in DNA unwinding 
(Iyer et  al., 2004;   Chong,  2005). Deletion    of    this    β-hairpin   structure 
uncoupled ATP hydrolysis from helicase  activity; with   the deletion mutant 
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Figure 1.5 Features of the monomeric and double-hexameric Mcm structural 
models: (A) Dodecameric structure of the N-terminal domain of M. 
thermautotrophicus Mcm (Fletcher et al., 2003) (B) Near full length 
structure of a single Mcm protein from S. solfataricus Mcm showing hairpin 
structures (Brewster et al., 2008) (C) Cartoon of M. thermautotrophicus 
Mcm single subunit indicating the relative positions of N-terminal, C-
terminal and AAA+ domains (Pape et al., 2003). 
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possessing increased ATP hydrolysis but no helicase activity (Jenkinson and 
Chong, 2006).  The S. solfataricus Mcm crystal structure confirms that this 
β-hairpin protrudes into the central channel of hexamer, supporting the 
predicted mechanical role of this β-hairpin (Brewster et al., 2008). A third β-
hairpin, EXT, in the C-terminal half of the protein is located close to the exit 
of the side channel. Mutations at the tip and the base of this β-hairpin have 
shown that it is required for helicase activity but not DNA binding (Moreau 
et al., 2007; Brewster et al., 2008). The fact that β-hairpins positioned in 
both the central and side channels of the complex are required for helicase 
activity supports the hypothesis that single stranded DNA is extruded 
through the side channel, as it is unwound. Three-dimentional reconstruction 
using electron microscopy indicates the relative positions of N-terminal, C-
terminal and AAA+ domain in M. thermautotrophicus Mcm (Figure 1.5 C). 
However, despite the large amount of biochemical data generated through 
structural and mutational analysis, the way in which DNA is passed through 
the Mcm complex and exact mechanism of unwinding remain unclear. 
 
1.6 Structure of the Mcm complex 
 
From studies using M. thermautotrophicus a three dimensional 
reconstruction of the Mcm complex has been achieved using negatively 
stained particles coupled with electron microscopy. Several reports shows 
that the Mcm protein has a hexameric ring structure with six individual 
monomers arranged around a six-fold axis. The large central cavity lined by 
the N-terminal domains and AAA+ domains of the monomers is wide 
enough to accommodate dsDNA (Figure 1.6 A, B) (Sato et al., 2000; Kalpan 
et al., 2003; Brewster et al., 2008). A three dimensional reconstruction of M. 
thermautotrophicus Mcm shows the top and bottom halves of the molecule 
are asymmetrical, the top half is dome shaped whereas the bottom half has a 
ridged shape; the ridge corresponds to the zinc motifs on each subunit 
(Figure 1.6 C). 
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Figure 1.6 Structure of the Mcm complex: (A) Crystal structure (ribbon 
diagram) showing the top and side views of a hexamer model of S. 
solfataricus Mcm (Brewster et al., 2008), (B) The channel of the double 
hexamer with modelled dsDNA (yellow) at the narrowest point (Fletcher et 
al., 2003) (C) Cryo-EM structure of top and bottom half of the molecule 
shows asymmetry, the top half is dome shaped (Pape et al., 2003). 
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1.6.1 Interactions between Mcm 2-7  
 
Purification of Mcm2-7 proteins as individual subunits of S. cerevisiae Mcm 
proteins as recombinant proteins in E. coli can be achieved and it was found 
that the Mcm heterohexamer could be reconstituted from these individual 
subunits (Davey et al., 2003). The Mcm subunits were studied individually 
and in many combinations to see if any ATPase activity was present. The 
study showed that individual Mcm subunits on their own could not 
hydrolyse ATP effectively (even though they have an ATP binding site); to 
achieve ATP hydrolysis two or more Mcm subunits are needed. Analysis of 
the Mcm2-7 active sites, both as isolated dimers and within the context of 
the Mcm2-7 heterohexamer indicated that they contribute unequally to ATP 
hydrolysis and viability (Bochman et al., 2008). ATPase activity requires 
residues from both subunits; a catalytic arginine on one subunit and an ATP 
binding site on the other subunit (Davey et al., 2003). There are fifteen 
possible combinations to pair up the six subunits and it was found that in the 
absence of DNA that only three of these combinations showed any ATPase 
activity. The three pairs that showed ATPase activity are; Mcm3/7 proteins 
(which showed the most ATPase activity), Mcm4/7 proteins (showed weaker 
ATPase activity) and Mcm2/6 proteins. These three pairs all showed 
significantly more ATPase activity than the heterohexamer of all six Mcm 
proteins (Davey et al., 2003). The suggestion that ATPase activity requires 
residues from two subunits was tested by analysing the activity of paired 
subunits with mutations. The arginine residues in catalytic SRF motif in the 
Mcm3 and Mcm7 were changed to alanine and then these mutated proteins 
were mixed with wild type proteins. It was shown that pairs containing 
mutant Mcm3 and wild type Mcm7 did not show any ATPase activity. 
Whereas mutated Mcm7 and wild type Mcm3 showed as much ATPase 
activity as the wild type Mcm3/7 pairing. This suggests that only one subunit 
provides the catalytic arginine (in this case it is Mcm3) whilst the other 
provides the ATP binding site (here it is Mcm7).  
 
Stable interactions between Mcm proteins were tested by mixing pairs of 
Mcm subunits and analysing their gel elution volume (the oligomeric state of 
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each Mcm protein can be determined by elution volume by comparing 
elution volumes to already known elution volumes of each Mcm subunit). 
Interactions have been shown between Mcm3/5 and Mcm4/6 and ambiguous 
results were found for Mcm pairs; Mcm2/3, Mcm2/4, Mcm3/4, Mcm3/6, 
Mcm6/7 so it was concluded that in the absence of any convincing data that 
these pairs of proteins do not interact with each other. From these observed 
interactions along with ATPase activities a proposed structure of a Mcm2-7 
heterohexamer is the ring shown in Figure 1.7 (Davey et al., 2003). The 
same organisation of subunits within the Mcm2-7 complex has been 
predicted in several independent studies (Crevel et al., 2001; Davey et al., 
2003; Yu et al., 2004; Bochman et al., 2008;).  It has been suggested that a 
discontinuity between the Mcm2 and Mcm5 subunits forms a “gate” that 
allows loading of the ring-shaped complex onto DNA (Bochman et al., 2008; 
Bochman and Schwacha, 2008). Although there are only three Mcm proteins 
that show ATPase activity  (Mcm3, 4 and 7) this does not mean that the 
other subunits are not catalytic, they may need extra factors to activate them 
in vivo that were not available in tests done in vitro. This may be a 
mechanism to make sure that the ATPase activity of the Mcm proteins is not 
on unless the Mcm hexamer is under the control of some other factors.  
 
1.6.2 Interaction of Mcm2-7 with other proteins 
 
Interactions have been described between Mcms and components of the 
origin recognition complex ORC, which was identified by its ability to bind 
to the conserved ARS consensus sequence of replication origins in S. 
cerevisiae (Bell and Stillman, 1992). ORC binds replication origins in vivo 
(Diffley and Cocker, 1992) and six components of the complex encoded by 
the ORC1 – 6 genes have been identified (Bell et al., 1993; Foss et al., 1993; 
Li and Herskowitz, 1993; Micklem et al., 1993; Bell et al., 1995; Loo et al., 
1995). Mutations in ORC genes cause defects in DNA replication, and 
reduce the efficiency of initiation at origins (Bell et al., 1993; Foss et al., 
1993; Micklem et al., 1993; Loo et al., 1995). The S. pombe homologue of 
Orc1 has been shown to interact with Mcm4 both genetically and 
biochemically (Grallert and Nurse, 1996)  and  genetic interactions have also  
 36 
 
 
 
Figure 1.7 Proposed structure of the Mcm2-7 heterohexamer: This structure 
is based on the interactions observed in the gel filtration analysis and 
ATPase activity. This ring is viewed from the C-terminal face. SRF 
represents the catalytic SRF motif (arginine finger) and P-loop (Walker A 
motif) represents the ATP binding site (Image and legend, Davey et al., 
2003). 
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been shown between the Mcm5 and ORC6 genes (Li and Herskowitz, 1993).  
 
In addition to this ORC interaction, both Mcm5 and Mcm7 were originally 
identified as extragenic suppressors of a mutation in the CDC45 gene (Moir 
et al., 1982), which encodes another essential replication factor (Hennessy et 
al., 1991) and this interaction was both dominant and allele specific. This 
interaction is most easily explained if Cdc45 physically associates with Mcm 
proteins and indeed the proteins have subsequently been shown to co- 
immunoprecipitate (Hopwood and Dalton, 1996). The role of Cdc45 in DNA 
replication is not known, but it also appears to interact at least genetically 
with ORC (Hardy, 1997; Zou et al., 1997). CDC45 is the eukaryotic 
orthologue of the bacterial and archaeal RecJ family nucleases (Makarova et 
al., 2012). In vitro and in vivo experiments have demonstrated that the 
Mcm2-7 helicase complex requires the association with GINS and the 
CDC45 protein and thought to be the active replicative helicase unit in vivo 
(Moyer et al., 2006; Pacek et al., 2006; Labib and Gambus, 2007). 
 
In addition to interacting with ORC and other initiation factors, which would 
potentially allow origin-specific association with chromatin, Mcms may also 
associate less specifically with nucleosomes via an interaction with histones. 
The tetrameric Mcm complex Mcm2, Mcm4, Mcm6, Mcm7 interacts with 
histone H3, which could be important for stabilizing the interaction between 
Mcm proteins and chromatin, or changing the stability of nucleosomes in the 
vicinity of replication origins (Ishimi et al., 1996). The Mcm2, Mcm4, 
Mcm6, Mcm7 tetramer does not interact with histone H2A or H2B and the 
dimeric Mcm subcomplex Mcm3, 5 appears to show no interaction with 
histones. The stability of the interaction between Mcm3 and Mcm7 and 
chromatin in extracted cells has been shown to be increased in the presence 
of ATP or non-hydrolysable analogues of ATP (Fujita et al., 1997) 
suggesting that ATP binding by Mcms or other chromatin proteins e.g., 
components of ORC, may in some way enhance the interaction with 
histones. Human Mcm3 was first described as a protein associated with 
DNA polymerase α primase (Thommes et al., 1992), although subsequent 
analysis failed to demonstrate a direct interaction between the two proteins 
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(Burkhart et al., 1995). However, genetic interactions have been found 
between subunits of DNA polymerase δ and Mcm2 in fission yeast 
(Forsburg et al., 1997). Archaeal GINS complex was identified and showed 
that it directly physically interacts with the archaeal Mcm (Marinsek et al., 
2006). Very recently interaction of McmA from M. maripaludis has been 
found with other hypothetical proteins namely MMP1213, MMP0004 and 
MMP0457 (Chong lab unpublished data). 
 
1.7 Regulation of Mcm helicase activity 
  
 
Two key classes of regulatory molecules, cyclins and cyclin dependent 
kinases (CDKs), determine a cell's progress through the cell cycle (Nigg et 
al., 1995). Cyclins form the regulatory subunits and CDKs the catalytic 
subunits of an activated heterodimer cyclins have no catalytic activity and 
CDKs are inactive in the absence of a partner cyclin. When activated by a 
bound cyclin, CDKs perform a common biochemical reaction called 
phosphorylation that activates or inactivates target proteins to orchestrate 
coordinated entry into the next phase of the cell cycle. Different cyclin-CDK 
combinations determine the downstream proteins targeted. CDKs are 
constitutively expressed in cells whereas cyclins are synthesised at specific 
stages of the cell cycle, in response to various molecular signals. 
 
CDK/cyclin (CDK) and Cdc7/Dbf4 (DDK) activity are required for the 
initiation of DNA replication in all eukaryotic cells (Stillman, 1996; Dutta 
and Bell, 1997) Phosphorylation plays a key role in regulating Mcm activity 
(Coue et al., 1996). 
 
In Xenopus, levels of Cdk2-cyclin E appear to be important for regulating 
Mcm chromatin binding. Although overall levels of Cdk2-cyclin E levels are 
similar throughout the embryonic cell cycle, compartmentalization of the 
kinase in newly formed nuclei gives rise to local concentrations around 
chromatin that are much higher than those in the cytosol (Hua et al., 1997).  
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Low levels of Cdk2-cyclin E or cyclin A are essential to allow formation of 
replication-competent chromatin, apparently because Mcm3 can only 
associate with chromatin under these conditions (Li et al., 2011). S. 
cerevisiae Cdks also seem to have a role in controlling the association of 
Mcms with chromatin. The ability of Mcm7 to associate with origins 
(Tanaka et al., 1997), or the ability of origins to form pre-RCs as defined by 
genomic foot-printing requires expression of Cdc6 during a period of low 
Cdk Cdc28-Clb activity. Cdk activity could in principle cause this effect by 
destabilizing Cdc6 and thus preventing both its association with chromatin 
and the subsequent binding of Mcms in S. cerevisiae (Piatti et al., 1997). 
 
In a related study in Xenopus egg extracts, Cdc2-cyclin B has also been 
shown to be an inhibitor of a component of replication licensing (Mahbubani 
et al., 1997), and in Drosophila, mitotic degradation of cyclin A but not 
cyclin B is required for rebinding of Mcms to chromatin (Su and O’Farrell, 
1997). Mcm4 may be phosphorylated by Cdk2/cylin A, since it contains 
consensus phosphorylation sites in the N-terminal region of the protein that 
are conserved amongst eukaryotes, and there is direct experimental evidence 
that it is a substrate in vitro (Kudoh et al., 2006). Examination of Mcm4 
during the Xenopus cell cycle provides evidence for Cdk phosphorylation. 
Mcm4 is hypo- or de-phosphorylated in G1 phase but chromatin-bound 
Mcm4 is phosphorylated in S phase before it is displaced by a replication 
fork (Coue et al., 1996). Recently it has been proved that the Dbf4–Cdc7 
kinase promotes S phase by alleviating an inhibitory activity in Mcm4 in S. 
cerevisiae (Sheu and Stillman, 2010). 
 
At least some Mcm proteins are phosphorylated in a cell cycle specific 
manner. Mcm2 from S. cerevisiae (Todorov et al., 1995; Young and Tye, 
1997) Mcm3 from S. cerevisiae (Young and Tye, 1997) Mcm4 from 
Xenopus (Hendrickson et al., 1996) and Mcm7 from human sources 
(Tsuruga et al., 1997) have been shown to be phosphoproteins. Mcm2, 
Mcm3 and Mcm4 proteins show a similar cell cycle pattern of 
phosphorylation, becoming dephosphorylated or hypophosphorylated on exit 
from mitosis, and being phosphorylated as cells enter S phase (Hendrickson 
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et al., 1994; Todorov et al., 1996; Young and Tye, 1997). Mcm proteins 
bound to chromatin are hypophosphorylated compared to the displaced 
proteins suggesting that phosphorylation triggers or shortly precedes the 
displacement of Mcms, or alternatively that phosphorylation can only occur 
on displaced Mcm proteins (Kimura et al., 1994; Musahl et al., 1995; 
Todorov et al., 1995; Hendrickson et al., 1996). For at least two Mcms, 
human Mcm2 and Xenopus Mcm4, the proteins are phosphorylated first in S 
phase, but become hyperphosphorylated during mitosis (Todorov et al., 
1995; Coue et al., 1996). 
 
Not much is known about the regulation of the archaeal Mcm helicase in 
vivo. In vitro studies on the regulation of the helicase yield conflicting 
results. To date, two proteins affect helicase activity in vitro. The 
M. thermautotrophicus and S. solfataricus Cdc6 protein (a homologue of the 
eukaryotic initiation protein Cdc6; also referred to as Orc or Orc/Cdc6) 
inhibits helicase activity in vitro (De Felice et al., 2003; Shin et al., 2003b; 
Kasiviswanathan et al., 2005). Cdc6 protein dissociates the hexameric 
helicase (Shin et al., 2008), which could be the mechanism by which 
helicase activity is eliminated. This dissociation of Mcm may also suggest a 
mechanism for helicase loading at the origin. The Mcm protein forms stable 
hexameric rings and these rings have to open at one interface, or to 
dissociate into monomers, prior to assembly at the replication bubble. This 
function may be mediated by Cdc6-mediated Mcm dissociation (Shin et al., 
2008). 
 
However, not all archaeal Cdc6 proteins inhibit their respective Mcm 
helicases. The Mcm protein from T. acidophilum exhibits very poor helicase 
activity on its own (Haugland et al., 2006; Haugland et al., 2009) but its 
activity is enhanced by the T. acidophilum Cdc6 protein (Haugland et al., 
2006). Binding of Cdc6 to Mcm protein stimulates the helicase ATPase 
activity and enhances helicase activity (Haugland et al., 2006; Haugland et 
al., 2008). Binding of Cdc6 to Mcm protein might induce conformational 
changes in the helicase that stimulate ATP hydrolysis. 
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Another archaeal protein that regulates helicase activity is the GINS 
complex from Pyrococcus furiosus (Yoshimochi et al., 2008). Like the Mcm 
helicase from T. acidophilum (Haugland et al., 2006), the in vitro helicase 
activity of the P. furiosus Mcm is very weak. However, it is stimulated upon 
interaction with the GINS complex (Yoshimochi et al., 2008) and, like the 
T. acidophilum Cdc6 protein (Haugland et al., 2008), GINS stimulates 
P. furiosus Mcm helicase activity by stimulating its ATPase activity 
(Yoshimochi et al., 2008). However, the effect of GINS on Mcm activity 
might not be a generalized phenomenon, because although Mcm and GINS 
proteins from S. solfataricus interact, no effect on Mcm helicase activity in 
vitro was observed (Marinsek et al., 2006). 
 
To date, in archaea, only the A. pernix Mcm protein was shown to be 
phosphorylated by a Cdc6 homologue (Atanassova and Grainge, 2008). 
Thus, phosphorylation or other modification might be involved in the 
regulation of the archaeal Mcm protein in vivo. 
 
1.8 Cancer and Mcm 
 
Association of the Mcm2-7 complex to ORC is a crucial moment in 
initiating the replication fork. Mcm proteins play a role in maintaining 
genome integrity and prevent re-replication once per cell cycle. Proliferating 
cells have high levels of Mcm, whereas they are not detected in quiescent, 
differentiated or senescent cells (Hiraiwa et al., 1997; Freeman et al., 1999; 
Meng et al., 2001; Ramnath et al., 2001; Going et al., 2002; Rodins et al., 
2002; Ishimi et al., 2003). They are also potentially useful markers of cell 
proliferation. Recent studies suggested that Mcms are good markers of 
proliferation activity, because they are highly expressed in a variety of 
tumours. Since molecular studies showed that increased levels of Mcms 
mark proliferative malignant cells (Ishimi et al., 2003) and may prove to be 
effective diagnostic markers for tumourigenesis (Todorov et al., 1998; 
Freeman et al., 1999; Stoeber et al., 1999; Lei, 2005). Studies on human 
Mcms are therefore potentially useful in providing targets for medicine or 
therapies.  
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Recently, several groups have reported that Mcm proteins are more 
frequently detected in cells from malignant tissues than those from normal 
tissues (Hiraiwa et al., 1997; Hiraiwa et al., 1998; Todorov et al., 1998; 
Williams et al., 1998; Freeman et al., 1999; Stoeber et al., 1999; Coleman et 
al., 2001; Endl et al., 2001; Stoeber et al., 2001; Tan et al., 2001; Wharton et 
al., 2001). This phenomenon was also observed in dysplastic cells (Freeman 
et al., 1999). Thus the presence of Mcms in precancerous cells and the 
potential reoccurrences (Alison et al., 2001; Hunt et al., 2002) make them 
effective markers. 
 
The fact that Mcms are over expressed in a cell cycle specific manner in a 
wide range of cancers means that they are not only potentially useful 
markers for cancers but that they also have the potential to be anti-cancer 
drug targets. There are several reports showing that Mcm helicase activity 
can be inhibited in vivo due to modifying Mcms (Ishimi et al., 2000; Takei et 
al, 2002). Cyclin A/Cdk2 phosphorylates human Mcm4 and inactivates the 
human Mcm4/6/7 complex helicase activity (Ishimi et al., 2000). Human 
Mcm2, 3 and 7 are phosphorylated by the ATM/ATR checkpoint kinases in 
response to DNA damage (Cortez et al., 2004; Shi et al., 2007). Over 
expression of human Mcm3 acetylating protein (Mcm3AP) inhibits the 
initiation of DNA replication (Takei et al, 2002). 
  
In vitro studies showed that Mcm2 could be efficiently silenced in human 
cells by RNAi or antisense oligodeoxynucleotides (ODNs) and this led to the 
inhibition of DNA replication. This study analyzes the transforming activity 
and signalling of Mcm7, the oncogenic function of the miRNA cluster that is 
embedded in the Mcm7 genome, and the potential of gene therapy that 
targets Mcm7 (Luo, 2011). Furthermore RNAi mediated knockdown of 
Mcm2-7 in human cells also increases in sensitivity to DNA damage (Ibarra 
et al., 2008). However, the tests have so far only been conducted in vitro and 
although several RNAi based therapies targeting other proteins are currently 
in clinical trials, delivering the antisense ODN/RNAi molecules to cancerous 
cells in vivo remains a significant problem (deFougerolles, 2008). 
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1.9 Model organisms to study Mcm complex 
 
Eukaryotes need cell cycle regulation control by DDK and CDK activity, the 
homologues of which are not present in archaea. It is thought that fewer 
proteins are needed in archaeal replication (Edgell and Doolittle, 1997). 
Methanogens were the first organisms to be identified as archaea and 
classified as a separate domain (Woese and Fox, 1977). Methanogens are 
divided into five orders: Methanobacteriales, Methanococcales, 
Methanomicrobiales, Methanosarcinales and Methanopyrales (Thauer, 
1998). Complete genome sequences for representatives of all of these orders 
are available. The observation that archaeal information processing systems 
are similar to but simpler than those in eukaryotes, along with the 
thermostable nature of proteins from many of these organisms, has led to a 
number of archaeal species being used as models for a variety of eukaryotic 
processes (Tye, 2000). DNA replication is a good example of how a 
eukaryotic process is simplified in archaea. In archaea that have been 
characterized to date, a single Mcm protein forms a homohexameric 
complex that possesses ATP-dependent DNA helicase activity (Chong et al., 
2000). Mcm complexes from a number of species have been characterized 
and have provided insight into the mechanisms that govern helicase activity 
in these proteins. Motifs essential for Mcm function have been identified 
using ATP hydrolysis, DNA binding and DNA helicase activity assays 
(Kelman et al., 1999; Chong et al., 2000; Shechter et al., 2000; Poplawski et 
al., 2001; Carpentieri et al., 2002; Kasiviswanathan et al., 2004; Jenkinson 
and Chong, 2006; Barry et al., 2007; Bochman and Schawacha, 2008). The 
genome sequence of Methanocaldococcus jannaschii (Mj) has revealed that 
in contrast to the single Mcm found in other archaea, this organism has 
multiple, apparently functional Mcm homologues (Bult et al., 1996).  
 
Methanococcus maripaludis is a mesophilic methanogen (Bult et al., 1996) 
that has one of the best-developed genetic systems of any organism in the 
archaea domain (Hendrickson et al., 2004). Because the genome of M. 
maripaludis S2 has been completely sequenced, this strain is the strain of 
choice for genetic manipulation (Jones, 1983; Hendrickson et al., 2004). 
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Analysis of the genome sequence of M. maripaludis S2 has revealed that it 
also contains multiple Mcms (Hendrickson et al., 2004; Walters and Chong, 
2009). A well-defined system for genetic manipulution of M. maripaludis, 
greatly increases its usefulness as a model system (Tumbula and Whitman, 
1999; Allers and Mevarech, 2005). The four M. maripaludis S2 Mcm 
homologues are distributed across the genome (Hendrickson et al, 2004) and 
are assigned ORF numbers that have further supplemented with gene names 
(indicated in parentheses) as MMP0030 (McmA), MMP0470 (McmB), 
MMP0748 (McmC) and MMP1024 (McmD) (Walters and Chong, 2010).  
 
It has been shown that Methanococcales have multiple functional Mcms 
(Walters and Chong, 2010) and may therefore be a good model for 
understanding eukaryotic Mcm interactions.  
 
1.10 Issues with eukaryotic Mcm studies 
 
In eukaryotes, in vivo observations implicate the Mcm2-7 complex as the 
replicative helicase (Bell and Dutta review, 2002). Despite this in vivo 
observation, Mcm2-7 has been reported to lack in vitro helicase activity 
(Schwacha and Bell, 2001; Davey et al., 2003; Bochman and Schwacha, 
2007). Interestingly, both an archaeal Mcm complex (Kelman and White, 
2005) and an alternative hexameric Mcm complex containing only three of 
the six eukaryotic Mcm subunits (the Mcm4/6/7 complex) have DNA 
unwinding activity (Ishimi, 1997; Lee and Hurwitz, 2001; Kaplan et al., 
2003). The helicase activity was only recently identified in S. cerevisiae 
Mcm2-7 complex expressed in baculovirus infected insect cells (Bochman 
and Schwacha, 2008).  
 
Although a lot of progress has been made in understanding eukaryotic Mcm 
there are still gaps that needed to be filled like how Mcms are loaded on to 
DNA? How and where exactly are Mcms modified to be regulated? 
Compared to archaeal systems, lots of replication origins and a requirement 
for other additional proteins partners makes it very difficult to dissect the 
exact process in eukaryotes. Also the post translation modifications that can 
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inhibit hexameric Mcm2-7 complex activity in eukaryotes make eukaryotic 
Mcm a difficult choice to work with. For this reason most of the research 
concerning Mcms are either on archaeal system or on simple eukaryotic 
system of yeast, Xenopus or Drosophila. 
 
1.11 Project Aims and Objectives  
 
  
An increased understanding of molecular Mcm function may aid in filling 
the gaps in DNA replication and regulation of DNA replication mechanisms 
and in identifying possible new targets for inhibition of cancer. Further 
understanding may also help in identifying new proteins involved in the 
replication process. 
 
Although S. cerevisiae Mcm2 - 7 have already been shown to possess 
helicase activity (Bochman and Schwacha, 2008), to date no one has 
performed a study on human Mcm and M. maripaludis for helicase activity.  
 
1.11.1 Aims  
 
The aim of this study is to investigate the human and M. maripaludis Mcm 
helicase activity by expressing the recombinant Human and M. maripaludis 
Mcm proteins in E.coli so that the inhibitory post translational modifications 
can be omitted. A further aim is to test the purified complexes for helicase 
activity and effect of phosphorylation on active Mcm2-7 helicase so that 
some insight into the regulation by inhibiting helicase activity by some 
kinases can be obtained. 
 
1.11.2 Objectives  
 
The objectives of this project were:  
 
•  To express and purify recombinant individual human Mcms and co-
express and co-purify human Mcms complex. 
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• To test human Mcm2-7 complex for helicase activity.  
 
• To test human Mcm2-7 complex as a target for kinase activity and 
whether phosphorylation modulates helicase activity? 
 
• To express and purify recombinant M. maripaludis Mcms  
 
• To test the M. maripaludis Mcm individual and in complex for 
helicase activity. 
 
• To determine the optimum conditions for M. maripaludis Mcms 
helicase activity.  
 
•  To find out the role of hypothetical proteins as a possible kinase that 
targets for M. maripaludis Mcm activity. 
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Chapter 2: Materials and Methods 
 
2.1 Chemicals, reagents and other materials   
 
All chemicals and reagents were supplied by Sigma-Aldrich (UK) unless 
stated otherwise. 
 
2.1.1 Primer design 
 
Primers used during PCR for amplification of DNA fragments were 
designed using Seqbuilder (Lasergene) software programme and ordered in 
lyophilized form from MWG Biotech. Primers were diluted to a final 
concentration of 100 μM in sterile dH2O (See Appendix 2 for detail). 
 
2.1.2 Growth media 
 
E.coli cells were cultured in Luria-Bertani or lysogeny broth (LB) liquid 
media containing 10 g tryptone, 10 g NaCl and 5 g yeast extract per litre. LB 
solid medium contained the same components as liquid LB, with 15 g/litre of 
agar added. LB media was sent to autoclave at 121 °C.  
 
2.1.3 Antibiotics 
 
All antibiotic stock solutions were filter sterilized before being added to 
growth media. Antibiotics were added to liquid and solid growth media to 
give the following final concentrations; 100 μg/ml ampicillin, 30 μg/ml 
kanamycin and 20 μg/ml chloramphenicol and 25 μg/ml spectinomycin 
unless stated otherwise, were used in this study. 
 
2.2 Sub-cloning and expression of hMcm2-7 
 
2.2.1 Plasmid construction 
 
Human Mcm2-7 cDNAs cloned into pBluescript SK+ vector were provided   
by the Mendez lab (CNIO Spain).  
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2.2.2 Transformation 
 
pBluescript SK+ vectors containing hMcm genes were transformed into the 
appropriate cells (E.coli Novablue). 1 μl of DNA (pBluescript SK+ vector) 
was added to 50 μl of cells on ice for 20 minutes and then heat shocked at 42 
oC for 45 seconds. Cells were placed back on ice for 2 minutes followed by 
the addition of 250 μl of SOC (0.5 g yeast extract, 2 g tryptone, 50 mg NaCl, 
2.5 mM KCl, 100 ml of sterile milliQ H2O, pH adjusted to 7.0 and solution 
autoclaved, then added 0.2 μm filter sterilized sterilized 10 mM MgCl2, 20 
mM glycerol). Transformed cells were incubated at 37 oC for 1 hour with 
moderate agitation (approximately 150 rpm). After 1 hour incubation, 100 μl 
of this culture was spread on to the appropriate antibiotic plate and incubated 
overnight at 37 oC. To extract DNA from colonies, over night colonies were 
grown in 5 ml of LB with appropriate antibiotics. 
 
2.2.3 Restriction digestion 
 
Reactions were carried out in a volume of 30 μl. 5 μg of extracted DNA was 
digested over the period of 1 hour at 37 oC by using 10 units of each of NEB 
restriction enzyme and 1x reaction buffer adjusted with water. 
 
2.2.4 Agarose gel electrophoresis 
 
Digested products were resolved on 1% Seaplaque agarose gel (Scientific 
solutions) at 100 v for 1 hour. The samples were loaded on the gel in the 
respective wells after mixing with 5 µl of 6x loading dye (30% glycerol, 
0.1% bromophenol blue). Gels were visualized on UV transilluminator and 
photographed with gel photo documentation system (Fuji). Q-Step IV DNA 
ladder  (York Biosciences) was used to estimate the size of DNA bands 
unless otherwise stated. 
 
 
2.2.5 Purification of restriction digest  
 49
 
 After running on gel, individual DNA bands were excised from the gel and  
purified using Wizard SV PCR clean-up kit (Promega) using the standard 
Manufacturer’s protocol. DNA concentration was measured on a nanodrop 
ND-1000 spectrophotometer (Thermo Scientific) using A260. For more 
concentrated DNA, ethanol precipitation was carried out.  
 
2.2.6 Ethanol precipitation 
 
 1/10th volume of 3 M sodium acetate (pH 5.2) was added to the purified 
DNA followed by 3x volume of 100% chilled ethanol and incubated on ice 
for 30 minutes. DNA was pelleted by centrifugation at 13,000 x g 
(Eppendorf, rotor F34-6-38) for 15 minutes at room temperature. 
Supernatant was removed and DNA was rinsed with 70% ethanol and 
centrifuged again at 13,000 x g (Eppendorf, rotor F34-6-38)  for 15 minutes 
at room temperature. Supernatant was removed and pellet was either dried at 
room temperature for 20 minutes or vacuum dried for 10 minute. Pellet was 
resuspended in 100 μl of TE pH 8.0. DNA concentration was measured 
using a on nanodrop ND-1000 spectrophotometer (Thermo Scientific).  
 
2.2.7 DNA ligation 
 
Total reaction volume for ligation was 10 μl that contained 50 ng of vector 
with either 1 or 3-fold molar excess of insert. T4 ligase and 1x reaction 
ligation buffer adjusted with water were added and centrifuged briefly and 
incubated either at room temperature (22 °C) for 1 hour or at 4 °C overnight.  
 
2.2.8 Sequencing 
 
After ligation the new vector containing hMcm gene was transformed into 
the appropriate cells (E.coli Novablue) as described in section 2.2.2.  
 
Over night colony growth showed the hMcm gene had been ligated into the 
vector. To confirm this, extracted DNA was digested with the same 
restriction enzyme used previously and compared to the expected band size. 
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Extracted DNA was sent for sequencing to the sequencing laboratory of 
York University (Technology Facility) or to MWG Biotech. Sequencing 
results were confirmed using SeqMan Pro DNA analysis software 
(Lasergene) for the presence of individual hMcm genes in respective vectors. 
Sequencing results showed that all of the genes were ligated correctly in 
vector pET47b but were out of frame, so site directed mutagenesis for all 
Mcms was performed to get them in the correct reading frame for 
expression. As the pET47b was used on direction of the Mendez lab (CNIO 
Spain) who provided the original clones but actually it should be pET47c 
vector that would have given the right frame.  
 
2.2.9 Site directed mutagenesis of hMcm2-7 genes 
 
To correct the reading frame of the constructs described above, hMcm2-7 
genes were subjected to site directed  mutagenesis (Stratagene, Quickchange 
SDM kit) following the manufacturers protocols and using the mutagenic 
primers of hMcm2-7 listed  in Appendix 2. Amplification conditions 
included 90 oC for 30 seconds followed by the 12 cycles of PCR (95 oC for 
30 sec, 55 oC for 1 minute, with a final 1 minute extension at 68 oC) 
 
PCR products were kept on ice for 1 minute and then 1 μl of DpnI added. 
These samples were incubated at 37 oC for 1 hour. The resultant constructs 
were use to transform 50 μl of DH5α cells with 1 μl of SDM-hMcm2-7. 
Obtained colonies were grown overnight at 37 oC in 5 ml of LB + antibiotics 
with 150 rpm shaking.  
 
2.2.10 Plasmid Preparation 
 
DNA was isolated from overnight cultures either by using Wizard Plus SV 
Miniprep DNA Purification Kit from Promega or the Miniprep DNA 
Purification System from Qiagen throughout this study. After mini 
preparation to recover DNA, all the genes were sequenced to ensure that 
they were in frame and there were no mutations introduced by PCR.  
 
2.2.11 Protein expression 
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2.2.11.1 Autoinduction 
 
Autoinduction medium was made in a volume of 1 Litre. For 1 L volume, 
added 1 ml of 1 M MgSO4 (24.65g MgSO4.7H2O, water to make up 100 ml, 
autoclaved separately), 1 ml of 1 M 10000X Metals (0.1 M FeCl3. 6H2O (in 
0.1 M HCl), 1 M CaCl2, 1 M MnCl2. 4H2O, 1 M ZnSO4. 7H2O, 0.2 M 
CoCl2. 6H2O, 0.1 M CuCl2. 2H2O, 0.2 M NiCl2. 6H2O, 0.1 M Na2MoO4. 
5H2O, 0.1 M Na2SeO3. 5H2O, 0.1 M H3BO3. 4H2O, autoclaved), 20 ml of 
50x 5052 (25 g glycerol, 73 ml water, 2.5 g glucose, 10 g α-lactose, 
autoclaved), 50 ml of 20x NPS (90 ml water, 6.6 g (NH4)2SO4, 13.6 g 
KH2PO4, 14.2 g Na2HPO4 pH, 6.75, autoclaved), appropriate antibiotic in 
ZY (10 g tryptone, 5 g yeast extract, 925 g water, autoclaved separately 
before addition of antibiotic). Autoinduction medium was inoculated with 1 
ml of a 5 ml of culture grown at 37 oC in LB medium for 8 hours with 180 
rpm shaking. After that culture was incubated at 30 oC for about 18 hours 
with 180 rpm shaking. 1 ml of culture was pelleted and resuspended in 100 
μl of water. 20 μl benzonase (Novagen), 6x loading buffer (30% 2-
mercaptoethanol, 12% SDS, 10% glycerol, 440 mM Tris pH 6.8, 0.1% 
bromophenol blue) was added and samples were boiled for 5 minutes at 100 
oC before loading on a 10% SDS-polyacrylamide gel. 
 
2.2.12 Cell culture  
 
5 ml of culture was grown overnight by the addition of a single colony to LB 
medium containing appropriate antibiotics. This was sub-cultured into 750 
ml of LB containing appropriate antibiotics and grown to optical density 
OD595nm 0.5-0.7. At this point 0.5 mM IPTG was added to the culture. 
Cultures were then incubated overnight with 180 rpm shaking at 37 oC.  
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2.2.13 Protein purification 
 
2.2.13.1 Sample preparation 
 
Cells were harvested from overnight culture by centrifugation at 4000 rpm 
(Eppendorf, model 5810 using swing out rotors A- 4-81) for 15 minutes at 4 
oC. The cells (4-7 g) were resuspended in 5 ml/g of lysis buffer (50 mM Tris 
pH 8.0, 300 mM NaCl, 5% Glycerol, 0.1 mM PMSF, 1 μM Pepstatin, 5 mM 
Imidazole, MilliQ water) followed by the addition of 0.75 mg/ml of 
lyzozyme and incubating at room temperature for 30 minutes to facilitate 
lysis. Samples were then sonicated for 3x 30 seconds at 100% power on ice. 
Insoluble material was removed by centrifugation at 30,000 x g (High Speed 
Sorvall Evolution, rotor F34) for 20 minutes at 4 oC.  
 
2.2.13.2 Binding protein to the column 
 
After preparing the Talon metal affinity resin bound with cobalt (Clontech) 
for purification by washing three times with wash buffer (50 mM Tris pH 
8.0, 300 mM NaCl, 5% Glycerol, 0.1 mM PMSF, 1 μM Pepstatin, 10 mM 
Imidazole, MilliQ water), soluble protein was added. The beads were 
incubated for 30 minutes at room temperature with agitation followed by a 
spin at 4,600 x g (Eppendorf, model 5810 using swing out rotors A- 4-81) 
for 5 minutes. After washing with wash buffer the protein was eluted from 
the beads with elution buffer (50 mM Tris pH 8.0, 300 mM NaCl, 5% 
Glycerol, 0.1 mM PMSF, 1 μM Pepstatin, 150 mM Imidazole, MilliQ water) 
and samples were run on 10% SDS-PAGE gels and eluant fractions were 
stored at -80 oC. Purified proteins were sent for mass spectrometry to 
confirm protein ID using trypsin digestion in proteomics laboratory, York 
University (Technology Facility). 
 
2.2.14 SDS-PAGE 
 
Mini gel system (CBS Scientific) was used for all SDS PAGE. 8% to 15% 
gels  were   used  throughout  this  study. For  hMcm  protein expression and  
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purification 12.5% gel was used. For resolving gel the correct percentage of 
Protogel pre mix (30% solution of 37.5:1 acrylamide:bis acrylamide, 
(National Diagnostics)  was mixed with 375 mM Tris pH 8.7 and 0.1 % 
SDS. Mixed gently 5 μl TEMED and 16 μl 10% APS to 5 ml of gel mixture 
and poured between plates. After the gel polymerized (40 min), poured off 
the overlay and added stacking gel. 5% final concentration of  acrylamide 
was mixed with 50 mM Tris pH 6.9 and 0.1% SDS for stacking gel. 5 μl 
TEMED and 16 μl of 10% APS were added to 2 ml of stacking gel mixture. 
After 5 minutes when stacking gel polymerized, samples were prepared by 
mixing 6x Laemmli buffer (30% 2-mercaptoethanol, 12% SDS, 10% 
glycerol, 440 mM Tris pH 6.8, 0.1% bromophenol blue) to the final 
concentration of 1x followed by 5 minutes boiling on hot block at 100 oC. 
Gels were run at 20 mA constant current per gel in 1x running buffer (25 
mM Tris base, 192 mM glycine and 0.1% SDS). 
 
Gels were stained with Coomassie blue R250 (40% MeOH, 10% Acetic 
acid, 0.1% coomassie blue (Fisher) and destained in 40% methanol and 10% 
acetic acid. Gels were then stored in gel preservative (18% ethanol, 5% 
glycerol).  Gels were either photographed using gel documentation system 
(Fuji) or scanned after drying overnight at 37 oC between dH2O wet acetate 
sheets. 
 
2.2.15 Silver staining of protein gels 
 
Gels were first fixed in 50% methanol for 2 x 15 minutes and then rinsed 
with dH2O. Gels were then washed for 20 minutes in 32.5 μM DTT followed 
by 20 minutes stained in 0.1% silver nitrate. After washing with dH2O, the 
gels were quickly rinsed with developer (3% sodium carbonate, 0.02% 
formaldehyde) till the bands became visible. To stop developing further, 5 
ml of 2.3 M citric acid was added for every 100 ml of developer and 
incubated for 10 minutes at room temperature. The gels were washed in 
dH2O for 30 minutes and then stored in gel preservative (18% ethanol, 5% 
glycerol) for photography or scanning.  
 
2.2.16 Protein quantification 
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Protein concentrations were determined by the Bradford reagent (Bio-Rad) 
using the Bradford method (Bradford, 1976) and plotting the values against a 
BSA standard curve and/or on the nanodrop ND-1000 spectrophotometer at 
A260. Concentrated proteins were flash frozen in liquid nitrogen and stored at 
-80 oC in small aliquots. 
 
2.2.17 hMcm 4/6/7 complex assembly  
 
As high imidazole concentrations were present in each of the protein 
fractions (hMcm4, 6 and 7) prior to assembling a complex, it was necessary 
to remove all salt. A HiTrap desalting column was used for this purpose. The 
column was connected to an AKTA system and washed with MilliQ water.  
The bound protein was then eluted in elution buffer (20mM Tris HCl, 1mM 
EDTA, 1mM EGTA, 1M KCl, 5% Glycerol, freshly added 0.1% β-
mercaptoethanol and 1 μg/ml Pepstatin). Equimolar amounts of each protein 
(Mcm 4, 6, 7) were pooled and applied to a Q-sepharose column. The 
sample was applied using a 2.5 ml syringe and eluted with a linear gradient 
of 0-100% of KCl from 50 to 1000 mM in 0.5 ml fractions. The fractions 
containing protein were pooled, samples of which were run on a 10% SDS-
PAGE gel. 
 
 2.3 hMcm complex co-purification by co-expression 
 
This work has been carried out in collaboration with Dr Richard Parker, a 
post-doctoral researcher in the Chong group. Using pET Duet LIC vectors 
Mcm 4, 6 was ligated into pCDF, Mcm 3, 5 in pRSF, Mcm 2, 7 in pET 
(Figure 2.1). All three vectors were co-transformed into BL21 Rosetta cells. 
A single colony was picked to express all six hMcm2-7 in 4.5 L of LB 
medium using kanamycin (15 μg/ml), ampicillin (25 μg/ml) and 
spectinomycin (25 μg/ml).  The cultures were incubated at 37 ºC with 
shaking until an OD600 of 0.887 was reached.  At that point, the cultures 
were incubated in   an iced water bath for 30 min.  IPTG was then added to a  
A 
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Figure 2.1 Constructs used for co-expression of human Mcms: (A) pET-32 
was generated by ligating Mcm2 and Mcm7. (B) pRSF-2 was generated by 
ligating Mcm3 and Mcm5 (C) pCDF-2 was generated by ligating Mcm4 and 
Mcm6. Each of the Mcms has a different N-terminal affinity tag for protein.  
final concentration of 0.1 mM. The cultures were then incubated for 24 
hours at 12 ºC with 180 rpm shaking. The cells were centrifuged for 10 min 
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at 4,600 x g (Eppendorf, model 5810 using swing out rotors A- 4-81)  at 4 
ºC, yielding a single pellet of 18 g, which was stored at -80 ºC until further 
use. A process flow diagram (PFD) is shown for protein purification steps of 
hMcm complex (Figure 2.2) 
 
2.3.1 Sample Preparation 
 
The pellet was immersed in a beaker of water at room temperature to thaw 
and once thawed kept on ice. The pellet of cells was re-suspended in 90 ml 
nickel binding buffer (25 mM Tris pH 7.6, 150 mM NaCl, 3 mM KCl, 40 
mM imidazole 10% glycerol, and freshly added 1 μg/ml Pepstatin A, 1 
μg/ml Aprotinin, 1 μg/ml Leupeptin, 0.5 μg/ml PMSF, 1 mM 2-
mercaptoethanol). The cell suspension was then passed through an 
automated cell disruptor (20 Kpsi) once and pooled.  Next, the following 
reagents were added:  6 mM MgCl2, 0.75 mg/ml lysozyme, 10 μg/ml DNase 
I and 5 μg/ml RNase A and the lysate was incubated for 10 min at room 
temperature with inversion.  Next, the lysate was clarified by centrifugation 
for 30 min at 50,000 x g (High Speed Sorvall Evolution, rotor F34) and 4 ºC.   
 
2.3.2 Ammonium sulphate precipitation 
 
Saturated ammonium sulphate was prepared by adding 110 g of ammonium 
sulphate to 200 ml of nickel binding buffer (minus protease inhibitors and 2-
ME), heating the solution to ~80 ºC and then cooling it to 4 ºC overnight 
while stirring. An equal volume of saturated ammonium sulphate solution 
was added to the clarified lysate and then incubated on ice for 30 min (with 
gentle mixing by inversion every 10 min) to precipitate the Mcm complex.  
The protein precipitate was centrifuged for 20 min for 10,000 x g 
(Eppendorf, rotor F34-6-38) at 4 ºC. The supernatant was discarded and the 
pellets were stored at -80 ºC until required for further purification. 
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Figure 2.2 A schematic representation of protein purification steps: The 
hMcm2-7 complex was purified over the range of chromatographic 
purification after ammonium sulphate precipitation as a first step of 
purification. 
 
 
 
 
 
 
 
 
2.3.3 Nickel column 
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The precipitated protein pellet was re-dissolved in nickel binding buffer to a 
volume 0.5x that of the original clarified lysate and then passed through a 
0.45 μm filter.  The first chromatographic step of the purification was a 1 ml 
nickel sepharose HP column with an imidazole step elution.  A flow rate of 
0.5 ml/min was maintained throughout the nickel column step.  First, the 
column was equilibrated with 5 column volumes (CV) of nickel binding 
buffer.  Next, the sample was loaded onto the column, which was then 
washed with 10 column volumes of nickel binding buffer.  Finally, the 
bound proteins were eluted using 100% nickel elution buffer (25 mM Tris 
pH 7.6, 150 mM NaCl, 3 mM KCl, 500 mM imidazole 10% glycerol, and 
freshly added 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 
0.5 μg/ml PMSF, 1 mM 2-mercaptoethanol). All 0.5 ml fractions were 
pooled together and further purified by size exclusion chromatography. 
 
2.3.4 Size exclusion chromatography 
 
A HiLoad 200 Superdex 16/60 column (GE Healthcare) was connected to an 
Äkta FPLC system at 4 ºC.  The column was first equilibrated with > 1.5 
column volumes of GF buffer (25 mM tris pH 7.6, 150 mM NaCl, 3 mM 
KCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA and freshly added 1 μg/ml 
Pepstatin A, 1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 0.5 μg/ml PMSF, 1 mM 
DTT).  The nickel elution pool sample was loaded into a 2 ml loop and 
injected onto the column.  Proteins were eluted isocratically with GF buffer 
at 1 ml/min and collected in a series of 2 ml fractions.  The fractions 
containing high molecular mass proteins as indicated by the first peak on the 
A280 chromatogram (i.e. A3-A6 8 ml) were pooled ready for the next 
chromatography step. 
 
2.3.5 Anion exchange 
 
The final chromatographic step utilised a 1 ml Source 15Q anion exchange 
column.  1ml/min flow rate was maintained through out this purification 
step.  2 volumes (16 ml) of sample dilution buffer were added to 1 volume of 
size exclusion pool (8 ml) in order to reduce the NaCl concentration to 50 
mM.  This sample was then loaded into a 50 ml super-loop.  The column was 
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rinsed with water, charged with Cl- ions with 5 column volumes of AIEX 
elution buffer (25 mM tris pH 7.6, 1000 mM NaCl, 3 mM KCl, 10% 
glycerol, 1 mM EDTA, 1 mM EGTA and freshly added 1 μg/ml Pepstatin A, 
1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 0.5 μg/ml PMSF, 1 mM DTT) and 
equilibrated with 5 CV of AIEX start buffer (25 mM tris pH 7.6, 50 mM 
NaCl, 3 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA and freshly 
added 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 0.5 μg/ml 
PMSF, 1 mM DTT).  The sample was then injected onto the column.  
Unbound material was then washed out of the column with 5 column 
volumes of AIEX start buffer.  The proteins were then eluted with a linear 
gradient of NaCl from 50 to 1000 mM over 20 CV and collected in 1 ml 
fractions. 
 
2.4 Purification of M. maripaludis Mcms 
 
Dr Alison Walters in the Chong group provided two constructs used in this 
section. One construct pAW 31 contained His-tagged MMP McmA and T7 
tagged MMP McmC in pCDF-2 while the other construct pAW 32 contained 
Trx-tagged MMP McmB and GST tagged MMP McmD in pET32 EK/LIC 
(Figure 2.3). 
 
2.5 Cell culture  
 
5 ml of culture was grown overnight by the addition of a single colony to LB 
medium containing appropriate antibiotics. This was used to inoculate 750 
ml of LB containing appropriate antibiotics and grown to optical density of 
OD595nm = 0.5-0.7. At this point 0.5 mM IPTG was added to the culture.          
Cultures were incubated for a further 24 hours with shaking at 180 rpm at 12 
oC. 
 
 
 
A 
 60
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Constructs used for purification of M. maripaludis Mcms: (A) 
pAW 31 containing His-tagged MMP McmA and T7 tagged MMP McmC in 
pCDF-2 (B) pAW 32 containing Trx-tagged MMP McmB and GST-tagged 
MMP McmD in pET32 EK/LIC.  
2.5.1 Protein purification 
 
2.5.1.1 His-tagged protein purification 
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A 4 g pellet was resuspended in 5 ml/g of lysis buffer (50 mM KPi pH 7.8, 
200 mM NaCl, 20% Glycerol, 10 mM Imidazole, 1x mini Roche protease 
inhibitor tablet, MilliQ water). 0.75mg/ml of lyzozyme was added to the 
mixture and was incubated at room temperature for 30 minutes to facilitate 
lysis. Samples were then sonicated for 3x 30 seconds at 100% power on ice. 
Insoluble material was removed by centrifugation at 30,000 x g (High Speed 
Sorvall Evolution, rotor F34) for 20 minutes at 4 oC.  
 
Ni-NTA resins were used to purify his-tagged MMP Mcms. Nickel beads 
were prepared for purification by washing with 5 resin volumes of wash 
buffer (50 mM KPi pH 7.8, 200 mM NaCl, 20% Glycerol, 50 mM 
Imidazole, 1x mini Roche protease inhibitor tablet, MilliQ water). These 
resin was transferred into  6 x 2 ml disposable gravity columns (Pierce) 
along with an equal volume of clarified cell lysate in each column and left 
for 2 hour on the rotor at 4 oC. After washing with 20 CV of wash buffer, the 
protein was eluted with 0.5 CV of elution buffer (50 mM KPi pH 7.8, 200 
mM NaCl, 20% Glycerol, 500 mM Imidazole, 1x mini Roche protease 
inhibitor tablet, MilliQ water) at first and then 2 CV afterwards. Samples 
were analysed on 10% SDS-PAGE gels and by western blot. Protein 
concentrations were determined as described in section 2.2.16. Eluant 
fractions were pooled, snap frozen in liquid nitrogen and stored immediately 
at -80 oC 
 
2.5.1.2 GST-tagged protein purification 
 
A 3 g pellet was resuspended in 5 ml/g of lysis buffer (50 mM Tris-Cl pH 
8.5, 250 mM NaCl, 1 mM EDTA, fresh 1 mM DTT). 0.75 mg/ml lyzozyme 
and 1mM PMSF were added and the mixture was incubated on ice for 30 
minutes to facilitate lysis. Samples were then sonicated for 5 pulses (50 W, 
20 kHz) on ice after adding 1% sarcosyl. Insoluble material was removed by 
centrifugation at 30,000 x g (High Speed Sorvall Evolution, rotor F34) for 
20 minutes at 4 oC. 12 ml of clarified cell lysate was transfered into 6 
disposable gravity columns (Pierce) containing 200 μl of glutathione-
sepharose to purify GST-tagged MMP Mcms proteins. Cell lysate was 
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incubated with slurry for 1 hour at 4 oC on a shaker. After washing with 0.5 
% Triton X-100, the protein was eluted with 0.5 CV of elution buffer (50 
mM glutathione, 50 mM Tris-Cl pH 8.5, 250 mM NaCl, 1 mM EDTA,) at 
first and then 2 CV afterwards. Samples were analysed on 10% SDS-PAGE 
gels and by western blot using antibiotics as detailed below. Protein 
concentrations were determined as described in section 2.9.7 Eluant fractions 
were pooled to subject to anion exchange (section 2.3.5)  
 
2.6 Western blotting 
 
Western blot were carried out using the transblot-SD semi dry transfer cell 
(BioRad). Proteins were separated using SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) providing information about molecular weight 
using pre-stained protein molecular markers (BioRad) so that efficient 
transfer could be easily confirmed. One sponge and 2 pieces of 3 mm filter 
paper (Whatman) soaked in anode buffer 1 (0.3 M Tris pH 10.4, 10% 
methanol) were placed on the anode plate. Another piece of filter paper 
soaked in anode buffer 2 (25 mM Tris pH 10.4, 10% mathanol) was placed 
and above that pre-soaked PVDF membrane (GE, Heathcare) in methanol 
was added. After placing the SDS polyacrylamide gel on top of PVDF 
membrane, 3 whatman filter paper and sponge soaked in cathode buffer (25 
mM Tris pH 9.4, 40 mM glycine, 10% methanol) were added. This stack 
was placed in the transfer apparatus and the transfer was carried out at 70 
mA for an hour. The membrane was separated from the rest of the stack after 
transfer and stained in 1x Ponceau S (BioRad). At this stage lane positions 
were marked. The membrane was then washed 2x for 20 minutes in wash 
buffer TBS (10 mM Tris pH 8.0, 150 mM NaCl) in case of Anti-TetraHis 
(Qiagen) and Anti-GST (Novagen) or TBS-T wash buffer (TBS, 0.1% 
Tween 20) for Anti-S (Novagen) and Anti-T7 (Novagen). The membrane 
was blocked for an hour in 20-30 ml of blocking buffer.  For Anti-TetraHis 
and Anti-GST 3% and fat-free dried 10% milk powder in TBS was used 
respectively and for Anti-S and Anti-T7 5% fat-free dried milk powder in 
TBS-T was used. Membranes were then washed 3x for 10 minutes and 
incubated in primary antibody overnight at room temperature. For Anti-
TetraHis and Anti-GST 1:5000 and 1:3000 with 5% fat-free dried milk 
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powder in TBS was used and for Anti-S and Anti-T7 1:5000 and 1:2000 
TBS-T was used. Membranes were then washed 6x 5 minutes with wash 
buffer (Table 2.1) and then incubated in secondary antibody for 1 hour. Anti-
rabbit-HRP 1:5000 in 10% fat-free dried milk powder TBS-T for Anti-
TetraHis and anti-mouse HRP (Zymed) 1:10000 TBS-T for Anti-S and Anti-
T7 and Anti-GST was used. Membranes were washed 3x 10 minutes in 50 
ml of wash buffer accordingly (Table 2.1). Protein was then detected using 
ECL Kit (Pierce) and wrapped in plastic cling film before exposing to 
photographic film (GE Healthcare). 
 
 
Antibody Wash 
buffer 
Blocking 
buffer 
Primary 
antibody 
dilution 
Secondary 
antibody 
Anti-TetraHis 
(Qiagen) 
TBS 3% BSA in 
TBS 
1:5000, 3% 
BSA in TBS 
Anti-rabbit-
HRP, 1:5000 in 
10%milk TBS-
T 
Anti-S 
(Novagen) 
TBS-T 5% milk in 
TBS-T 
1:5000 TBS-T Anti-mouse-
HRP (Zymed), 
1:10000 TBS-T 
Anti-T7 
(Novagen) 
TBS-T 3% BSA in 
TBS-T 
1:20000 TBS-
T 
Anti-mouse-
HRP (Zymed), 
1:10000 TBS-T 
Anti-GST 
(Novagen) 
TBS 10% milk in 
TBS 
1:4000 5% 
milk in TBS 
Anti-mouse-
HRP (Zymed), 
1:20000 TBS-T 
  
 
Table 2.1 Antibody and buffer solutions used for western blots: 
 TBS: 10 mM Tris pH 8.0, 150 mM NaCl; TBS-T: TBS plus 0.1% Tween 
20. 
 
 
2.7 Substrate preparation for helicase assays 
 
A forked substrate was generated by annealing a 32P-labelled 57 base 
oligonucleotide (HS2) and a non-labelled 74 base oligonuleotide (HS1) to 
produce a forked DNA substrate with a 25 bp double-stranded region. 
(Figure 2.4). 50 pmol of 57 base substrate was radiolabelled using 3 μl of 
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Chapter 3: Biochemical studies on human Mcms 
 
3.1 Introduction  
 
Initiation of eukaryotic DNA replication requires the assembly of 
multiprotein complexes at the replication origin (Stillman, 1996). The 
minichromosome maintenance proteins form a hexameric complex required 
at the time of DNA replication initiation and provide the replicative DNA 
helicase activity that includes DNA dependent ATPase activity (Chong et 
al., 2000). Mcm helicase complexes are conserved in all eukaryotic 
organisms and are composed of six different but highly related proteins. 
Mcm complexes can be isolated from eukaryotic cells as several stable 
subassemblies (Thommes et al 1997). Weak DNA helicase activity was 
identified in a human complex of a dimer of trimers containing Mcm4/6/7 
that was only sufficient to displace some 30bp of short oligonucleotides from 
complementary DNA templates (Ishimi, 1997). Recently it has been 
demonstrated that S. cerevisiae Mcm2-7 complex expressed in baculovirus-
infected insect cells has helicase activity in vitro (Bochman and Schwacha, 
2008). However to date no studies from human Mcms expressed in E. coli 
have shown helicase activity. In order to achieve robust activity of hMcm, 
we expressed and purified hMcms from E. coli so that proteins would not 
contain any post-translational modifications that are present in protein 
purified from eukaryotic sources. We tested this complex for helicase 
activity. Furthermore we investigated the affect of phosphorylation on 
helicase activity of hMcm2-7 complex. 
 
 
3.2 Cloning, expression and purification of individual human Mcms 
 
 
3.2.1 Plasmid construction 
 
Human Mcms 2-7 cDNAs cloned into pBluescript SK+ vector were provided 
by the Mendez lab (CNIO Spain). The hMcm genes (2-7) were subcloned 
into the expression vector pET 47b (Novagen) using following restriction 
sites. hMcm2 was digested with BamH1 and Xho1 and inserted into BamH1 
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and Xho1 sites of pET 47b to yield a pET 47b-Mcm2 construct. Mcms 3, 4, 
5, and 7 were digested with EcoR1 and Xho1 and were inserted into EcoR1 
and Xho1 of pET 47b to yield pET 47b-Mcm3, pET 47b-Mcm4, pET 47b-
Mcm5 and pET 47b-Mcm7 constructs. Mcm6 was digested with Xho1and 
Sal1 and inserted into Xho1and Sal1 sites of pET 47b to yield pET 47b-
Mcm6 construct. Sequencing results showed that all of the genes were 
ligated correctly in vector pET 47b but were out of frame, so site directed 
mutagenesis for all Mcms was performed (See section 2.2.9 in materials and 
methods) to place them in the correct reading frame for expression. A 
summary of human Mcms proteins properties is provided in table 3.1. 
 
3.2.2 Expression  
 
3.2.2.1 Small-scale expression 
 
Initial expression and solubility studies were carried out by growing 50 ml 
cultures of individual proteins. Mcms were found to over express well in 
small-scale cultures but the majority of proteins were packaged into 
inclusion bodies (IBs). For increasing solubility, different temperature trials 
were carried out after induction. Amongst 12 oC, 16 oC, 25 oC and 37 oC, it 
was found out that for Mcm4, 12 oC  was best and for rest of the Mcms 37 oC 
was working.  
 
To increase the solubility of recombinant proteins different strains were used 
in trials. These were Rosetta BL21, Rosetta BL21 (DE3), Arctic Express 
(DE3) RIL and Arctic Express (DE3) pLysS. Rosetta host strains are 
designed to enhance the expression of eukaryotic proteins that contain 
codons rarely used in E. coli (Brinkmann et al., 1989; Seidel et al., 1992; 
Kane, 1995; Kurland and Gallant, 1996). While DE3 indicates that the host 
is a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 
RNA polymerase gene under control of the lacUV5 promoter (Studier et al., 
1990; Dubendorff and Studier, 1991a; Dubendorff and Studier, 1991a). 
Arctic Express (DE3) RIL cells are optimised for expression of recombinant 
proteins at low temperature  because they   contain a   plasmid expressing the  
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Table 3.1 Summary of human Mcm2-7 proteins properties: Properties 
described are for untagged proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hMcm Gene length 
(bp) 
Residues 
(aa) 
Mol. weight 
(Da) 
pI 
hMcm2 2715 904 101891 5.34 
hMcm3 2427 808 90977 5.53 
hMcm4 2592 863 96552 6.28 
hMcm5 2209 734 82283 8.64 
hMcm6 2466 821 92883 5.29 
hMcm7 2160 719 81303 6.08 
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chaperons Cpn10  and Cpn60 from the psychrophillic bacterium Oleispira 
antactica. These chaperones are homologues of the E.coli chaperones GroEL 
and GroES, and are adapted to function optimally at 4-12 oC and therefore 
allow protein folding at low temperature (Lund, 1994). pLysS strains express 
T7 lysozyme, which further suppresses basal expression of T7 RNA 
polymerase prior to induction (Moffatt and Studier, 1987; Studier, 1991).  
There was not any significant difference in solubility of Mcms between these 
strains therefore Rosetta BL21 (DE3) was widely used in these studies. 
 
 Different buffers were used throughout this study for protein purification. A 
buffer system that worked for one Mcm did not necessarily worked for other 
Mcms, so each of the buffer systems is discussed with reference of 
individual purified Mcm in the respective sections. 
 
Furthermore expression vectors were also considered to change. For this 
purpose Mcm5 and Mcm6 were individually ligated into pQE-31 vector but 
only Mcm6 was purified this way (discussed later in section 3.2.5). 
 
For SDS-polyacrylamide gel, samples were prepared by addition of 20 µl 
benzonase nuclease (Novagen) 6x loading buffer into 100 µl total protein. 
Samples were boiled for 5 minutes at 100 oC before loading on a 10% SDS-
polyacrylamide gel (Figure 3.1).  
 
3.2.2.2 Large-scale expression 
 
For large-scale expression, 750 ml of media with appropriate antibiotics was 
used to grow cultures in a 2 litre flask.   
 
3.2.3 Protein purification   
 
Proteins were purified either manually by using disposable gravity columns 
(Pierce) or a Tricorn 5/50 column (GE Healthcare) using an AKTA prime 
automated purification system. Mcm6 and Mcm7 were purified from  750 ml 
of culture using the same set of buffers while Mcm4 was purified from 4.5 L 
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Figure 3.1 Expression of hMcm2-7: Expression trials of individually (His)6-
tagged hMcms 2-7 in autoinduction medium from total protein fractions 
showed that all individual proteins were expressed in E. coli. Individual 
proteins were expressed in Rosetta E.coli BL21 (DE3) cells at 37 oC. Small 
arrowheads near each protein indicate the individual protein band 
corresponding to their sizes (See table 3.1). 
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of culture with different set of buffers (Section 3.2.4). 
 
Differences in each of the hMcm purifications are discussed under each 
section of the respective protein purifications. 
 
3.2.4 Expression and purification of hMcm4 
 
Initial expression and purification trials indicated that hMcm4 had low 
solubility reducing the amount of protein that could be purified from cell 
extract. Therefore this protein was expressed in 4.5 litre of culture rather 
than 750 ml as for the other Mcms.  Recombinant Mcm4 was expressed at 
12 ºC in Rosetta DE3 cells and purified from a 4.5 litre culture that yielded a 
cell pellet weighing 21 grams. 
 
As nickel gives different binding characteristics from cobalt.  i.e. Ni2+ is the 
metal ion considered to have the strongest affinity to histidine-tagged 
proteins and may therefore allow binding and washing under more stringent 
conditions (higher imidazole) and therefore removal of more contaminants 
that could have purified due to expressing protein at 12 ºC in Rosetta DE3 
cells.  It was hope that an imidazole gradient will elute non-specifically 
bound proteins before the hMcm4 was eluted. 
 
The buffers used for the hMcm4 purification were different to those used for 
the other Mcm purifications.  The pellet was resuspended in 40 ml of nickel 
binding buffer (50 mM sodium phosphate pH 7.4, 0.5 M NaCl, 10% 
glycerol, 30 mM Imidazole, 1 mM 2-mercaptoethanol and 1x Roche 
complete EDTA free protease inhibitor mixture).   The cells were lysed by 
one pass through a manual French press rather then sonication. 
 
A Tricorn 5/50 column (GE Healthcare) column was used for washing and 
elution. The bound protein was eluted with a linear gradient of 0-100% 
elution buffer H (50 mM sodium phosphate pH 7.4, 0.5 M NaCl, 10% 
glycerol and 500 mM imidazole) over a period of 40 min at 5 ml/min. The 
eluate was collected in a series of 2 ml fractions, samples of which were run 
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on 10% SDS-PAGE gels. The ~ 57 KDa E.coli chaperone GroEL protein 
was present in large amounts  (Fraction containing GroEL protein not shown 
in the gel) although it appeared to be washed from the column before 
hMcm4 had finished eluting. The SDS-PAGE gel showed a very clean band 
at the expected size of hMcm4 (96 KDa) just near the 100 KDa protein 
marker (Figure 3.2). Samples containing only hMcm4 were pooled together 
and concentration of which was measured. The final volume of protein was 
10 ml and the concentration was calculated to be 15. 1 µg/ml by Bradford 
assay (See section 2.2.16 in Materials and Methods). 
 
3.2.5 Expression and purification of hMcm 6 
 
The gene for hMcm6 (which was initially ligated into pET47b) was digested 
with BamH1 and Sal1 and inserted into BamH1 and Sal1 sites of pQE-31 to 
yield pQE-31- hMcm6 construct.  
 
It was noted that no induction was required for pQE-31- hMcm6. The pQE-
31 vector uses a T5 promoter as opposed to a T7 promoter used commonly 
in other expression systems. The T5 promoter is recognized by the E. coli 
RNA polymerase and the lac operator sequence, which binds lac repressor 
and ensures efficient repression of the powerful T5 promoter in E. coli. pQE-
31-hMcm6 construct was sequenced before expressing protein and was 
confirmed that Mcm6 gene was full length. 
 
hMcm6 was expressed from 750 ml of culture, yielding 1.5 gram of pellet 
and  purified under the conditions described in section 2.2.13 using the same 
set of buffers. Elution fraction samples 1 and 2 were run on 10% SDS-PAGE 
gels (Figure 3.3) and remaining fractions were flash frozen in liquid nitrogen 
and stored at -80 oC. Protein bands were visible in elution fraction 1 and 
elution fraction 2, just below the expected size for hMcm6 (93 KDa). 
Purified hMcm6 protein ID was confirmed by mass spectrometry (MS). The 
possible explanation of hMcm6 mobility being smaller then expected size in 
SDS-PAGE gel is its degradation during expression and purification steps.  
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Figure 3.2 Purification of hMcm4: SDS-PAGE analysis of fractions from 
purification trials visualised by Coomassie blue staining. Protein was 
expressed in E.coli BL21 (DE3) Rosetta cells at 12 oC overnight. Pellets 
from 4.5 L of culture was resuspended, and the soluble protein fraction was 
bound, washed and eluted from nickel beads using 500 mM imidazole. 
hMcm4 protein band of 96 KDa in the elution fraction is visible. Protein ID 
was confirmed by mass spectrometry (MS). 
TP, total protein; SF, soluble fraction; UB, unbound fraction; EF, elution 
fraction 
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Figure 3.3 Purification of hMcm6: SDS-PAGE analysis of fractions from 
expression trials after Coomassie blue staining. Protein was expressed in 
E.coli BL21 (DE3) Rosetta cells at 37 oC overnight. 750 ml culture pellet 
was resuspended and the soluble fraction bound, washed and eluted from 
Talon beads using 150mM imidazole. hMcm6 protein band is visible  around 
75 KDa in the elution fraction below its expected size of 93 KDa . The 
protein ID was confirmed by mass spectrometry. This protein might have 
degraded during purification steps thus the mobility is smaller then expected 
size.  
TP, total protein; SF, soluble fraction; UB, unbound fraction; EF, elution 
fraction 
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The final volume of protein was 5 ml and the protein concentration was 
calculated to be the 15.8 µg/ml by Bradford assay (See section 2.2.16).  
 
3.2.6 Expression and purification of hMcm7 
 
hMcm7 was expressed in 500 ml culture which yielded 2 gram of pellet. 
hMcm7 protein was purified under the conditions described in section 2.2.13  
using the same set of buffers. Samples of the protein eluted with elution 
buffer were run on 10% SDS-PAGE gels and eluant fractions were stored at 
-80 oC. The SDS-PAGE gel showed a clean band at the expected size for 
hMcm7 (81 KDa) near the 75 KDa protein marker (Figure 3.4). The final 
volume of protein was 6 ml and the concentration was calculated to be 15.5 
µg/ml by Bradford assay (See section 2.2.16). 
 
3.2.7 Expression and purification of hMcm2, 3, 5 
 
Despite trying several trials that included changes in buffers for purification, 
expression conditions, different temperatures for purification of hMcm2, 3 
and 5, all attempts were largely unsuccessful. hMcm2 showed a very small 
amount of solubility in E.coli Arctic Express (DE3) RIL cells but this was 
not enough to carry out further assays. Also for further assays all 6 proteins 
needed to be purified. 
 
3.3 hMcm 4/6/7 complex 
 
An attempt to assemble a first complex of hMcm4/6/7 was not successful. 
The apparent reason seemed to be proteolysis, but the addition of protease 
inhibitors did not make any difference.  
 
The concentration of the proteins purified was too low (hMcm4 was 15.1 
µg/ml, hMcm6 was 15.8 µg/ml and hMcm7 was 15.5 µg/ml) to perform 
further assays on them. As all six Mcm proteins were needed for helicase 
and further assays, there was no point to concentrate these proteins.  
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Figure 3.4 Purification of hMcm7: SDS-PAGE analysis of fractions from 
expression trials after Coomassie blue staining. Protein was expressed in 
E.coli BL21 (DE3) Rosetta cells at 37 oC overnight. The pellet from a 500 
ml culture was resuspended and eluted from Talon beads using 150 mM 
imidazole. A protein band of 81 KDa in the elution fraction was visible at 
the expected size for hMcm7. This band was later confirmed by mass 
spectrometry. 
TP, total protein; SF, soluble fraction; UB, unbound fraction; EF, elution 
fraction 
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Results of expression and purification trials showed that hMcm7 expressed 
at 37 oC. However under these conditions other hMcms were not present in 
the soluble fraction of cell extracts. hMcm6 could be purified only after 
expressing in pQE-31- hMcm6 construct under the same buffers as described 
for hMcm7 but the same approach for hMcm5 did not yield purified protein. 
Purification of hMcm4 was possible by expressing it at low temperature in 
E.coli BL21 (DE3) Rosetta cells in 4.5 L of culture.  
 
Even after all these attempts the level of purified protein was very low. 
Eventually Mcm2 was also purified using low temperature after induction. 
As we hypothesized that all six were necessary for robust helicase activity 
therefore without the purification of hMcm3 and 5, further assays could not 
be performed.  It was then decided that the individual protein purification 
approach should be discontinued. 
 
3.4 Cloning, co-expression and co-purification of human Mcms 
 
The expression and purification of individual hMcms showed that hMcm 2, 
3 and 5 were insoluble and difficult to purify. As all of the effort to get them 
in soluble form remained largely unsuccessful. Also the concentration 
obtained from hMcm 4, 6 and 7 proteins was small in amount and varying in 
purity making it very difficult to proceed towards reconstituting a complex. 
Furthermore the attempts to make a hMcm4/6/7 complex failed so it was 
decided to conduct a trial to co-express and co-purify all these proteins for 
further assays. 
 
Co-expression of interacting proteins can increase the solubility of 
recombinant proteins. As Mcm2-7 interacts with each other (Davey et al., 
2003), therefore co-expression and co-purification could provide an increase 
in solubility of insoluble Mcms. Often the separate components of a complex 
are not soluble mostly due to hydrophobic patches that are exposed to the 
solvent (Damodaran, 1986). These patches are usually involved in and 
protected by the binding to the other component of the complex (Kurochkina 
and Mesyanzhinov, 1999). Therefore, co-expression of the different 
 84 
components could result in a higher expression level of soluble protein 
complex. 
 
3.4.1 Plasmids construction for co-expression of hMcms 
 
This work has been carried out in collaboration with Dr Richard Parker, a 
post-doctoral researcher in the Chong group. For hMcm2-7 subunit cloning, 
LIC vectors (Novagen) were used. cDNAs encoding the six hMcm subunits 
(hMcm2-7) were cloned in pairs into three pET Duet vectors (Novagen) to 
allow co-expression of all six subunits in E. coli. First, each cDNA was PCR 
amplified from the constructs provided by Mendez lab (CNIO Spain) using 
primers with 5’ sequences designed to be compatible with the ligation 
independent cloning (LIC) system employed by the Duet vectors. The 
amplicons were gel purified and treated with T4 DNA polymerase in the 
presence of dATP in order to recess the 3’ ends. Each pair of hMcm cDNAs 
was annealed with a Duet vector backbone and an adaptor DNA segment 
according to the Novagen LIC kit directions. hMcm2 and hMcm7 cDNAs 
were annealed with the pET32 Ek/LIC vector and the T7 Ek/LIC adaptor to 
give: pET32-hMcm2 and hMcm7. hMcm6 and hMcm4 cDNAs were 
annealed with the pCDF-2 Ek/LIC vector and the GST Ek/LIC adaptor to 
give: pCDF-2-hMcm4 and hMcm6. hMcm5 and  hMcm3 cDNAs were 
annealed with the pRSF Ek/LIC vector and the minimal Ek/LIC adaptor to 
give: pRSF- hMcm3 and hMcm5 (See Appendix 2 for primers sequences). A 
detailed modified diagram of the predicted interactions of the six 
recombinant Mcm proteins in a heterohexameric complex from Davey et al., 
(2003) with different N-terminal tags that were used in affinity purification 
was created (Figure 3.5). Overall three vectors encoding six different 
proteins were generated. One vector contained hMcm2 and hMcm7 with an 
N-terminal T7-tag on hMcm2 and an N-terminal S/his/trx-tag on hMcm7. A 
second vector contained hMcm4 and hMcm6 with an N-terminal GST-tag on 
hMcm4 and an N-terminal his-tag on hMcm6. The third vector contained 
hMcm5 and hMcm3 with an-N terminal his-tag on hMcm5.  
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Figure 3.5 Diagram of the predicted interaction of the six recombinant Mcm 
proteins, in a heterohexameric complex with different affinity tags used for 
multistep protein purification (adapted from Davey et al., 2003). 
 
 
 
GST 
His 
His 
T7 
S 
His 
Trx 
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Extra molecular weight was added due to tags and linkers on the proteins. A 
linker was placed between the proteins (hMcm2-7) and the tag. Linkers (or 
adaptors) were created from synthetic oligonucleotides, providing sequence 
overlaps with each of two sequences that were to be joined.  
 
The number of residues and molecular weight of each hMcm2-7 was 
calculated with different tags on them and are given in table 3.2. 
 
3.4.2 Co-expression 
 
Three plasmids containing six Mcm proteins in pairs were used to co-
transform E.coli BL21 (DE3) Rosetta cells (See section 2.3). As from the 
knowledge of individual protein purification trials, it was most difficult to 
purify Mcm4 compared to Mcm6 and Mcm7, therefore it was decided to 
follow the steps that were used to express Mcm4.  Like Mcm4 was 
expressed in E.coli BL21 (DE3) Rosetta cells with low temperature, it was 
decided to follow the same approach. Rosetta cells containing all three 
vectors were used to inoculate 6 x 750 ml of LB containing appropriate 
antibiotics. These cultures were incubated at 37 ºC with 200 rpm shaking 
until an OD600 of 0.887 was reached and then chilled for 30 min.  IPTG was  
then added to a final concentration of 0.1 mM.  The cultures were then 
incubated at 12 ºC with 180 rpm shaking for a further 24 hours. The cells 
were harvested by centrifugation, and were stored at -80 ºC prior to protein 
purification. 
 
3.4.3 Multi-step purification 
 
A number of chromatographic steps were carried out to co-purify the co-
expressed hMcms. The steps included in the purification scheme were 
ammonium sulphate precipitation, affinity chromatography, size exclusion 
chromatography and anion exchange chromatography (Figure 2.2).  
 
The 18 grams of pellet (which was from 4.5 litre of culture) was purified 
first through ammonium sulphate  purification. Ammonium  sulphate is used 
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to purify proteins by altering their solubility, as its solubility is so high that 
salt solutions with high ionic strength are allowed (Chick and Martin, 1913). 
At low salt concentrations, the solubility of the protein increases with 
increasing salt concentration (salting in). As the salt concentration (ionic 
strength) is increased further, the solubility of the protein begins to decrease. 
At sufficiently high ionic strength, the proteins almost completely precipitate 
from the solution (salting out). After salting out, from 50% saturated 
ammonium sulphate solution, the pellet was stored at -80 ºC until further  
purification. 
 
The first chromatographic step of the purification after ammonium sulphate 
purification was a nickel sepharose HP column with 500 mM imidazole step 
elution (See section 2.3.3). Elution was carried out using an AKTA 100 at 4 
oC. The SDS-PAGE analysis showed that the complex eluted across four 0.5 
ml fractions (2 ml total), which were pooled together and stored at 4 oC for 
the next purification step by size exclusion chromatography. 
 
Size exclusion chromatography was carried out by using Superdex-200 
16/60 column (120 ml bed volume). Affinity purified protein (2 ml) was 
loaded onto the column that was then connected to an ÄKTA FPLC system 
(4ºC).  Proteins were eluted with gel filtration buffer and collected in a series 
of 2 ml fractions (Materials and methods section 2.3.4).  The fractions 
containing high molecular mass proteins as indicated by the first peak on the 
A280 chromatogram (i.e. A3-A6) were pooled (4x 2 ml) and subjected to a 
final purification step. 
 
For anion exchange step an automated ÄKTA 100 system was used. The 
sample was injected onto the Tricorn 5/50 column that was packed with 
Source 15Q resin (GE Healthcare) after diluting in anion exchange start 
buffer (Materials and methods section 2.3.5) in order to reduce the NaCl 
concentration to 50 mM so that the protein could be bound to the column 
and eluted from 50 to 500 mM NaCl gradient by changing the ionic strength.  
The proteins were eluted with a linear gradient of NaCl from 50 to 500 mM 
and collected in 1 ml fractions. The fractions from clarified lysate, 
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ammonium sulphate supernatant, resuspended ammonium sulphate pellet, 
nickel column pool, nickel column flow through, and size exclusion elution 
were analysed by the SDS-PAGE (Figure 3.6). The Coomassie blue stained 
gel showed several bands were present below the expected molecular weight 
(See table 3.2 for sizes of hMcm2-7) suggesting protein degradation during 
different steps or it may be contamination with other non-specific proteins. 
A few bands were present above the expected molecular weights in the 
ammonium sulphate precipitation and nickel column chromatography steps 
but were not present in size exclusion. There is a dark band in the nickel 
column fraction that could be degradation of proteins through nickel 
purification. A lot of protein is going in to nickel column flow through. The 
numbers of non-specific higher and lower bands other than expected 
molecular weight bands were significantly reduced after size exclusion 
chromatography (Figure 3.7). However, the hMcm2-7 as visualised on a 
Coomassie blue stained SDS-PAGE, individual subunits as well as the 
presence of some putative degradation products but it is clear that if all the 
hMcms were present in final chromatographic step, all six proteins were not 
in equal amount. 
 
The presence of all six hMcm subunits needed to be confirmed at the end of 
the purification by western blotting using specific antibodies. Western 
blotting was carried out on fraction A13 of anion exchange chromatography 
elution to confirm the presence of each hMcm in final step of purification. 
Using antibodies specific to each of the hMcm western blot was performed. 
hMcms 5, 6 and 7 were detected at around the 100 KDa marker in anti-His-
tag western blot using anti-tetra-His antibody (Qiagen). The western blot for 
anti-T7-tag was performed in presence of anti-T7-tag monoclonal antibody 
(Novagen) and detected the presence of hMcm2, which migrated just above 
the 100 KDa markers. Anti-S-tag western blot of anion exchange fraction 
A13 against anti-S-tag monoclonal antibody (Novagen) resulted in the 
detection of hMcm7 that migrated just above the 100 KDa markers. In anti-
hMcm3 western blot of anion exchange fraction A13, membrane was probed 
with anti-hMcm3 monoclonal antibody (MBL) confirmed the presence of 
hMcm3 that migrated to just above  the 75 KDa markers. This  antibody also  
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Figure 3.6 Co-purification of hMcm2-7: 10% SDS-PAGE analyses of 
fractions from multi-step purification of co-expressed proteins. A Coomassie 
blue stained gel showed several bands were present above and below the 
expected molecular weight, along with expected sizes of hMcm2-7 proteins 
that could due to contamination or protein degradation. The 20 µl of samples 
from various stages of purification were loaded as follows: A) clarified 
lysate, B) ammonium sulphate supernatant, C) resuspended ammonium 
sulphate pellet, D) Nickel column fractions pool, E) Nickel column flow 
through, F) Size exclusion column fractions pool.  A thick band near 50 KDa 
marker in nickel column fraction seems to indicate the presence of some 
putative degradation products. 
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Figure 3.7 Anion exchange chromatography for purification of hMcm2-7: 
SDS-PAGE analysis of fractions from the anion exchange column stage. A 
Coomassie blue stained gel showed six individual bands were present at the 
expected sizes for hMcm2-7 in several fractions from anion exchange 
chromatography. A few low molecular weight bands were also visible which 
could be the degradation of hMcm2-7 proteins due to multi-step purification. 
Arrowheads indicate expected bands of individual hMcm2-7. 
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cross reacted with some lower molecular mass bands that might be the result 
of proteolysis products. Anti-hMcm4 western blot was carried out in the 
presence of anti-hMcm4 (Santa Cruz Biotechnology) and gel showed the 
expected band just above the 100 KDa markers with some other non-specific 
bands which could be protein degradation or some contamination or even 
non specific binding to antibody. The presence of hMcm6 protein in elution 
fraction was detected by using anti-hMcm6 (BD Biosciences) in anti-hMcm6 
western blot and showed that the hMcm6 migrated between the 100 and 150 
KDa markers (Figure 3.8). 
 
SDS PAGE analysis and western blots indicated the presence of all six 
hMcms, after various co-purification steps. The intensity of different bands 
of each hMcm varied in the elution fractions of anion exchange 
chromatography suggesting that all six hMcms were not present in equal 
amounts. Several bands were present below the expected molecular weight, 
suggesting protein degradation during different steps. An alternative 
explanation for the bands could be contamination from other proteins.  
 
To date the exact stoichiometry of hMcm complex has not been accurately 
measured. If the approach of purifying individual Mcms would have been 
successful for all of the Mcms, it might have been possible to form 
homogeneous complexes. By using analytical ultra centrifugation, the 
molecular weight of individual complexes could have been measured and 
stoichiometry of hMcm complex would have been measured by quantitative 
mass spectrometry. Quantification of the hMcm complex was possible by 
using MALDI-MS fingerprinting by running six analyses of each 
homohexamer complex. The abundance of the six proteins in a co-purified 
fraction varied significantly and in the presence of low molecular weight 
contaminating proteins or protein degradation in the final purification step 
made it difficult to use this complex to estimate stochiometry. 
 
Similarly the use of different tags on different Mcms had given the choice to 
co-purify these Mcms with different tags using pull down assays and it could 
have    suggested  that  Mcms could  make  heterohexamer   complex. As the  
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Figure 3.8 Western blot of co-purified hMcm2-7: Western blot analysis of 
elution fraction A 13 from anion exchange chromatography of co-expressed 
hMcms. Using antibodies against each of the hMcm2-7 showed that all six 
hMcms were present in elution fraction of anion exchange chromatography. 
Anti-T7 for hMcm2, anti-hMcm3 monoclonal antibody for hMcm3, anti-
hMcm4 for hMcm4, anti-His-tag for hMcm5, anti-hMcm6 for hMcm6 and 
anti-S-tag monoclonal antibody for hMcm7 were used. Arrowheads indicate 
positions of individual hMcm2-7. This blot was provided by Dr. Richard 
Parker. 
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Mcms have similar biochemical properties, it is also possible that because of 
similar properties of these six proteins, homohexamers of each protein are 
co-purifying or making a combination of homohexamers and 
heterohexamers. 
 
The final concentration of this complex was measured by Bradford assays 
and the concentration of this complex was found to be 0.28 mg/ml. As the 
amount of purified protein was very low and a further protein concentration 
step might result in loss of protein, therefore it was decided that this protein 
would not be concentrated. These purified proteins were further 
characterised using helicase assays and kinase assays. 
 
3.5 Helicase assays for human Mcms 
 
The main purpose of purifying hMcms was to carry out helicase assays to 
determine whether hMcm 2-7 has the ability to separate two annealed 
oligonucleotides efficiently in vitro.  A strand displacement or helicase assay 
was carried out using a forked substrate that was generated by annealing a 
radiolabelled 57 bases γ[32P]ATP oligonucleotide and non-radiolabelled 74 
bases oligonucleotide (See appendix 2 for sequences) resulting in a 25 bp 
double stranded complementary region. The helicase assay was performed in 
the presence of helicase buffer (See section 2.7.2). Increasing protein 
concentrations (50 nM to 500 nM) were used while the substrate 
concentration remained 1 nM for each reaction. Reactions were carried out 
for 1 hour at 37 oC and then stopped by the addition of helicase stop buffer 
that contained EDTA to inhibit ATP-dependent enzyme activity. Four 
negative controls were generated by incubating reaction on ice, adding 
EDTA at the start of reaction, omitting protein from the reaction and just 
running substrate without buffer, along with one positive control that was 
prepared by boiling the substrate at 100 oC for 5 minutes in the helicase 
buffer with subsequent addition of helicase stop buffer. Reactions were 
electrophoresed on a pre-run 12% (polyacrylamide) TBE gel to visualize the 
separated labelled oligonucleotide. After drying, the gel was exposed to a 
phosphorimager screen.  
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Protein dependent helicase activity was shown by the hMcm complex. 
Unwinding started significantly at protein concentration of 5 nM and peaked 
at 200 nM (Figure 3.9A and B). After 200 nM, there were very faint signals 
just below the expected bands, suggesting nuclease activity due to 
contamination. 
The helicase activity was measured using densitometry on Quantity One 
software (BioRad) and a graph was plotted between DNA unwound and 
protein concentrations (Figure 3.9B) where the boiled substrate was taken as 
to displace DNA 100% in graphic values. 
 
3.6 Assays for the activity of kinases on human Mcms 
 
Kinase activity assays were carried out to test the phosphorylation of 
purified hMcm2-7. Cyclin dependent kinases (CDK) phosphorylate Mcms 
on serine and threonine amino acids with the help of cyclin (Masai et al., 
2000). Without cyclin, CDK has a little or no kinase activity, so the active 
form is a CDK/cyclin. Two complexes, CDK 2/cyclin A and CDK 2/cyclin 
E (provided by Dr Cyril Sanders, The University of Sheffield) were used 
separately to test their activity on human Mcms in vitro. Assays were carried 
out in 20 µl of kinase buffer (See section 2.8) with subsequent addition of 
γ[32P]ATP and kinase complexes. Kinase activity was measured by the 
γ[32P]ATP incorporated into hMcm complex over the period of 30 minutes at 
37 oC. Reactions were stopped by the addition of stop buffer and the samples 
were analysed on 4-12% polyacrylamide gradient gel. Gels were then 
exposed to film or phosphorimager screen overnight to detect 
phosphorylation. 
 
WT human Mcm2-7 complex was strongly phosphorylated by both 
complexes, CDK 2/cyclin A and CDK 2/cyclin E. Mutant hMcm2-7 
complex (each hMcm was truncated from C terminal) was provided by Dr 
Richard Parker, a post-doctoral researcher in the Chong group to test if the 
mutant hMcm2-7 complex could   also act  as a substrate for phophorylation. 
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Figure 3.9 (A) Helicase activity of human Mcm2-7: PAGE analysis of strand 
displacement assays of hMcm complex with various protein concentrations. 
This activity was measured by the amount of displaced single stranded DNA 
from with double stranded substrate over the period of 1 hour at 37o C. Each 
helicase assay was performed at least three times. The possible explanation 
of faint signals just below the expected bands could be contamination due to 
nuclease activity. 
 
 
Figure 3.9 (B) Quantification of 
helicase activity of human 
Mcm2-7: Densitometry was used 
for quantification of strand 
displacement activity compared 
with boiled substrate and 
indicated as a percentage and 
plotted on a graph. Helicase 
activity increased with increase 
in protein concentration to 200 
nM and then gradually 
decreased. 
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Deletion of a C-terminal domain from the M. thermautotrophicus Mcm 
protein resulted in more processive helicase activity (Jenkinson and Chong, 
2006), therefore each human Mcm subunit was truncated from C-terminal 
and purified over range of chromatographic steps as explained for full length 
wild type human Mcm complex. CDK 2/cyclin E showed more robust 
activity compared to CDK 2/cyclin A. Wild type human Mcm2-7 complex 
showed stronger signals of phosphorylation  (Figure 3.10 A and B). There 
was another strong band below the expected band size, above 36 KDa 
marker in CDK 2/cyclin E gel (Figure 3.10 B), consistent with the 
autophosphorylation activity of cyclin E (47 KDa) as reported previously 
(Won and Reed, 1996). 
 
Mass spectrometry is a useful technique to identify the phosphorylated 
residues. Phosphorylation sites of human Mcm complex could be quantified 
by using mass spectrometry but due to PhD time frame as a limiting factor, 
samples were not sent for mass spectrometry. This could be done in future to 
identify known and novel phosphorylated sites on Mcms. 
 
3.7 Helicase activity of phosphorylated human Mcm2-7 complex 
 
hMcm4,6,7 complex helicase activity was shown to be inhibited when 
Mcm4 was phosphorylated by CDK 2/cyclin A (Ishimi et al., 2000). To test 
if phosphorylated human Mcm2-7 complex still had helicase activity, strand 
displacement assays were carried out on phosphorylated human Mcm2-7 
complex as explained in section 2.7.2. Reactions were analysed on a 
12%TBE gel that was exposed to a phosphorimaging screen overnight.  
 
As the phosphorylation activity was better with CDK 2/cyclin E, thus this 
complex was used for further assays of kinase activity to see the effect of 
phosphorylation of the hMcm complex on its helicase activity. As the 
protein concentration of 50 nM to 200 nM showed robust helicase activity so 
the increasing amount of phosphorylated hMcm2-7 protein concentration (50 
nM to 200 nM) was used to perform the helicase assays on phosphorylated 
hMcm2-7   complex. Boiled   substrate and  two different  concentrations   of 
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Figure 3.10 Phosphorylation of human Mcm2-7 WT and mutant complex:  
(A) with CDK 2/cyclin A (B) with CDK 2/cyclin E. Protein samples (human 
Mcm complex wild type and human Mcm complex mutant) were incubated 
at RT for 30 minutes in a kinase buffer in presence of CDK 2/cyclin A or 
CDK 2/cyclin E before running on a 4 to 12% SDS gradient polyacrylamide 
gel. The gels were exposed overnight to X-ray film to detect 
phosphorylation.  Control reactions were performed without adding any 
human Mcm protein complex. Arrowhead near 150 KDa protein markers 
showing the phosphorylation on hMcm complexes, while another arrowhead 
near 36 KDa protein markers on figure B showed the autophophorylation of 
cyclin E. Another arrow indicates the presence of p70, which is common 
contamination of Cdk protein purification. 
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dephophorylated hMcm2-7 complex generated three positive controls. In the 
control reaction 1 and 2, dephophorylated hMcm2-7 protein showed good 
helicase activity while the phosphorylated hMcm2-7 did not show any 
helicase activity (Figure 3.11). These results showed that when the complex 
was phosphorylated by CDK 2/cyclin E, its helicase activity was 
significantly reduced. A super-shift was observed in all phosphorylated 
hMcm2-7, which is consistent with published (Jenkinson and Chong, 2006), 
and unpublished data where a super-shift was found in negative controls or 
reactions where no helicase activity was observed. This result confirms that 
CDK 2/cyclin E negatively regulates the helicase activity of human Mcm 
complex. 
 
3.7 Discussion  
 
Despite trying various protocols, buffers and vectors, different conditions, 
individual human Mcms remained largely insoluble. hMcm4, 6 and 7 were 
purified eventually with low solubility. hMcm6 was purified using the pQE 
vector under T5 promotor to increase the expression levels.  hMcm4 
solubility increased when induced at the lower temperature of 12 oC after 
addition of IPTG. To get more protein, hMcm4 was purified from 4.5 L of 
culture. Even after all these efforts, not enough proteins were purified to 
carry out further assays on them. It was then decided to try to co-purify these 
proteins, which could help the solubility of these proteins by interacting with 
each other during the expression and purification steps. All six proteins were 
co-purified successfully over multiple purification steps, although there were 
various low molecular weight bands visible in the gel, suggesting protein 
degradation in these steps. Protein co-purification over several 
chromatographic steps suggests protein/protein interactions of hMcm in 
vitro. Helicase activity was tested on co-purified hMcms successfully. hMcm 
showed robust protein-dependent helicase activity. This confirms that hMcm 
possesses a reproducible DNA helicase activity. Furthermore the hMcm 
complexes were tested as a target for kinase activity in the presence of CDK 
2/Cyclin A and CDK 2/Cyclin E complex.  CDK 2/Cyclin A and 
CDK2/Cyclin E phosphorylated the hMcm complex. As the phosphorylation 
 100 
 
 
Figure 3.11 Helicase activity of phophorylated human Mcm2-7: PAGE 
analysis of strand displacement assays of phosphorylated hMcm complex 
with various protein concentrations. Control 1 and control 2 were generated 
by performing the helicase assays on two different concentrations of 
dephosphorylated hMcm2-7 complex (50 nM and 70 nM). Phosphorylated 
hMcm2-7 complex did not show any helicase activity and a supershift of the 
substrate was observed with all concentrations of phosphorylated hMcm2-7 
complex. 
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by CDK 2/cyclin E complex was better then CDK 2/Cyclin A therefore 
phosphorylated hMcm complex with CDK 2/cyclin E was further tested for 
helicase activity. Phosphorylated hMcm2-7 complex did not show any 
helicase activity and a super-shift was observed in helicase assays of 
phosphorylated hMcm2-7 complex. These results suggest that 
phosphorylation of hMcm2-4 complex by CDK 2/cyclin E down-regulates 
hMcm helicase activity. 
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Chapter 4: Biochemical studies of M. maripaludis Mcms 
 
 
4.1 Introduction  
 
Replication in archaea appears to be a simplified version of the eukaryotic 
process as fewer polypeptides participate in each phase of replication (Edgell 
and Doolittle, 1997). Thus, archaea represent the simplest model to study the 
molecular mechanisms of eukaryotic DNA replication (Tye, 2000). 
Extensive research has been carried out on archaeal Mcms. In all eukaryotes 
six Mcm helicase proteins are found but this is not true for archaea. The 
genome of Methanococcus maripaludis S2 has been sequenced and revealed 
that this archaeon contains four Mcm homologues (Hendrickson et al., 2004) 
while Methanothermobacter thermautotrophicus has just a single Mcm that 
forms a double hexamer complex and has an ATP-independent DNA-
binding activity which can distinguish between single stranded and double 
stranded DNA and 3’-5’ helicase activity that requires of ATP hydrolysis 
(Kelman et al., 1999; Chong et al., 2000; Shechter et al., 2000). Archaeal 
Mcms provide the best examples of biochemical activity in Mcms todate. 
 
Purified recombinant MMP (Methanococcus maripaludis) Mcms both 
individually and in combination were provided by Dr Alison Walters in the 
Chong group (Walters and Chong, 2010). As the concentration of MMP 
McmD and MMP Mcm complex were very low and poor quality, trials were 
conducted to co-purify proteins from the two constructs pAW 30 and pAW 
31 provided by Dr Alison Walters (Walters and Chong, 2010). Furthermore 
M. maripaludis individual MMP Mcms designated (MMP McmA, MMP 
McmB, MMP McmC and MMP McmD) and complex were tested for 
helicase activity. A number of different experiments were performed to 
determine the optimum conditions for helicase activity of these proteins.  
 
4.2 Co-purification of M. maripaludis Mcms 
 
 
M. maripaludis Mcms were co-purified from two constructs. One construct 
contained MMP McmA and T7 tag adaptor upstream of MMP McmC into 
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pCDF-2 designated as pAW 31 while the other construct contained MMP 
McmB and GST tag adaptor on MMP McmD in pET32 EK/LIC designated 
as pAW 32 (Figure 2.3).  
 
As the hMcm4 seemed to be the most difficult protein to purify amongst the 
human purified proteins, therefore it was decided to use the similar approach 
of hMCM4 to purify these MMP Mcms, that is to use Rosetta E. coli BL21 
(DE3) cells at low temperature after induction but with different sets of 
buffers (Materials and methods section 2.5). Two pellets from two different 
expression constructs were harvested by centrifugation at 4000 rpm for 15 
minutes at 4 oC. 
 
4.2.1 Purification of his-tagged protein 
  
pAW 31 contained a his tag on MMP McmA and T7 tag on MMP McmC. It 
was decided to purify this protein using the his-tag. 
 
 Harvested pellets were resuspended in resuspension buffer (See section 
2.5.1.1 in Materials and Methods) before storing at -80 oC until further use. 
Proteins were purified from 750 ml of culture using Talon beads. Elution 
fractions were separated by 10% SDS-PAGE (Figure 4.1). Coomassie 
stained gels showed a band of protein just above the 75 KDa marker. As the 
molecular weights of MMP McmB and MMP McmC were 77 KDa and 78 
KDa respectively, this band could be the result of one or two proteins being 
purified over Talon beads. To confirm whether this thick band was actually 
from two different proteins, western blots were carried out on three elution 
fractions.  Western blot using anti-his for MMP McmA and anti-T7 for 
MMP McmC antibodies indicated the presence of both proteins in all three 
elution fractions (Figure 4.3 A and C). The large number of bands in the 
anti-his western blot of elution fraction 1 could be contamination or protein 
degradation.  
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Figure 4.1 Purification of co-expressed MMP McmA and MMP McmC: 
SDS-PAGE analyses of fractions from purification trials. Proteins were 
expressed in E.coli BL21 (DE3) Rosetta cells at 12 oC overnight. 750 ml 
culture pellet was resuspended and eluted from nickel beads using 500 mM 
imidazole. A band of protein is visible at the expected sizes of the proteins, 
this could be due to a single protein as the sizes of the two proteins are very 
close to each other 77 KDa (MMP McmA) and 78 KDa (MMP McmC). 
Western blots were carried out to confirm the presence of two proteins in 
elution fractions (See figure 4.3). 
 
TP, total protein; SF, soluble fraction; UB, unbound fraction; EF, elution 
fraction 
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4.2.2 Purification of GST-tagged protein 
 
pAW 32 expression construct contained S-tag on MMP McmB and GST tag 
on MMP McmD. It was decided to purify this protein using GST-tag. 
 
Harvested pellets were resuspended in resuspension buffer (See section 
2.5.1.2) before storing at -80 oC until further use. Proteins were purified from 
750 ml of culture using glutathione sepharose beads. Elution fractions were 
separated by 10% SDS-PAGE (Figure 4.2). Coomassie stained gel showed a 
protein band just below 100 KDa protein marker which was expected for 
MMP McmB band of 93 KDa and a faint band just over 100 KDa protein 
marker which could be MMP McmD (108 KDa). There were non-specific 
bands below the expected bands; therefore, one further step of anion 
exchange was carried out as explained in section 2.3.5. After anion exchange 
chromatography step, MMP McmD, which was largely insoluble, was not 
present (Figure 4.2).   
 
Western blot (See section 2.6) using anti-S for MMP McmB and anti-GST 
for MMP McmD antibodies indicated that two proteins were being purified 
in elution fractions 1, 2 and 3 (Figure 4.3 B and D). 
 
4.2.3 Quantification of purified proteins 
 
Purified proteins were quantified using Bradford assays. The concentration 
of proteins from the pAW31 construct was 5 mg/ml in a volume of 18 ml. 
The concentration of proteins from pAW32 construct was 2 mg/ml and the 
volume was 10 ml. 
 
Although the concentrations of MMP Mcm proteins were greatly enhanced 
by this method of purification, the MMP McmD was mainly in the insoluble 
fraction. It was then decided to use the MMP Mcm complex (MMP McmA, 
MMP McmB, MMP McmC and MMP McmD) provided by Dr Alison 
Walters for further helicase assays although the concentration of provided 
MMP Mcm complex was 0.256 mg/ml. 
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Figure 4.2 Purification of co-expressed MMP McmB and MMP McmD: 
SDS-PAGE analyses of fractions from muti-step purification trials. Proteins 
were expressed in E.coli BL21 (DE3) Rosetta cells at 37 oC overnight. Cells 
from 500 ml culture were lysed and protein from soluble fraction was 
purified using 50 mM glutathione and further purified using anion exchange 
chromatography. A protein band of 93 KDa for MMP McmB was visible in 
EF1 (Nickel chromatography) and EF2 (anion exchange chromatography). A 
faint band of 108 KDa (MMP McmD) was present in EF1 but not in further 
purification steps. 
 
TP, total protein; SF, soluble fraction; UB, unbound fraction; EF1, Nickel 
chromatography; AX, elution fraction from anion exchange chromatography 
 
 
 
 
 107 
A      B 
    
 
 
 
 
 
 
 
 
 
 
 
C      D 
 
 
Figure 4.3 Western blot analysis of elution fractions of co-purified protein: 
Western blot analysis of differently tagged MMP Mcms showed that all the 
proteins were co-purified using (A) Anti-his tag for MMP McmA, (B) Anti-
S for MMP McmB, (C) Anti-T7 for MMP McmC, (D) Anti-GST for MMP 
McmD. Although the signals from western blot confirmed the presence of 
each of Mcm but the use of positive and negative control would have 
provided further evidence to impact on results. 
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4.3 Helicase assays for M. maripaludis Mcms 
 
 
Protein sequence analysis showed that all four Mcms in M. maripaludis 
might be functional, as they all possess highly conserved motifs in their 
sequences (Walters and Chong 2010), which are helix-2 insert, pre-sensor 1 
β-hairpin and arginine finger. On that basis helicase activity assays were  
performed for all four Mcms individually.  Strand displacement assays were 
carried out using a forked substrate that was generated by 57 bp 32P-labelled 
oligonucleotide and non-labelled 74 bp oligonucleotide that annealed to 
produce a 25 bp double-stranded complementary region.  The helicase assay 
was performed in the presence of helicase buffer (Section 2.7.2). Increasing 
protein concentrations (5 nM to 50 nM) were tested while the substrate 
concentration remained 1 nM for each reaction. Reactions were carried out 
for 1 hour at 37 oC and then stopped by the addition of helicase stop buffer 
(Section 2.7.2) that contained EDTA to inhibit unwinding. A negative 
control was generated by performing the reaction without adding any protein 
along with one positive control that was prepared by boiling the substrate at 
100 oC for 5 minutes in helicase buffer with subsequent addition of helicase 
stop buffer. Reactions were electrophoresed on a pre-run 12% TBE gel to 
visualize the separated labelled oligonucleotide. After drying, the gel was 
exposed to a phosphoimager screen overnight and imaged using a 
phosphoimager (BioRad). Each experiment was performed at least three 
times with representative gels being shown. 
 
MMP McmA and B showed protein dependent helicase activity (Figure 4.4 
and 4.5) while MMP McmC did not display any activity or if there was any, 
it was  a very low level of activity (Figure 4.6). MMP McmD was also tested 
for helicase activity and it did not show any helicase activity. MMP Mcm 
complex also showed robust helicase activity (Figure 4.7). However, the 
stoichiometry of the MMP Mcm complex was not determined, and it was 
possible that several heteromeric complexes composed of different Mcm 
subunits could be formed (Walters and Chong, 2010). On that basis it might 
be possible that in MMP Mcm complex, only MMP McmA and B were 
playing  a  major role in  helicase  activity.  The results from McmD helicase 
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Figure 4.4 Helicase activity of MMP McmA: Increasing amounts of purified 
MMP McmA protein was added to 32P-labelled DNA substrate with a 25 bp 
double-stranded region and incubated at 37oC for 1 hour. Reactions were 
analysed by separating the dsDNA substrate and unwound single stranded 
32P-labelled oligonucleotide using PAGE and exposing the gel to a 
phosphorimaging screen overnight. MMP McmA (A) showed robust protein 
dependent helicase activity. (B) The helicase activity was quantified using 
densitometry. Boiled substrate was considered to displace DNA 100% in 
graphic values.  
 
 No protein was used as a negative control while boiled substrate was a 
positive control.   
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Figure 4.5 Helicase activity of MMP McmB: Increasing amounts of purified 
MMP McmB protein was added to 32P-labelled DNA substrate with a 25 bp 
double-stranded region and incubated at 37oC for 1 hour. Reactions were 
analysed by separating the dsDNA substrate and unwound single stranded 
32P-labelled oligonucleotide using PAGE and exposing the gel to a 
phosphorimaging screen overnight. MMP McmB (A) showed robust protein 
dependent helicase activity. (B) The helicase activity was quantified using 
densitometry. Boiled substrate was considered to displace DNA 100% in 
graphic values. 
 
No protein was used as a negative control while boiled substrate was a 
positive control.   
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Figure 4.6 Helicase activity of MMP McmC: Increasing amount of MMP 
McmC purified protein was added to a 32P-labelled DNA substrate with a 25 
bp double-stranded region and incubated at 37oC for 1 hour. Reactions were 
analysed by separating the dsDNA substrate and unwound single stranded a 
32P-labelled oligonucleotides using PAGE and exposing the gel to the 
phosphorimaging screen overnight. MMP McmC (A) did not show any 
helicase activity or there may be very level of activity. (B) The helicase 
activity was quantified using densitometry. Boiled substrate was considered 
to displace DNA 100% in graphic values. 
 
The negative control was a reaction that did not contain protein while boiled 
substrate was a positive control.   
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Figure 4.7 Helicase activity of MMP Mcm complex: Increasing amount of 
purified Mcm proteins were added to a 32P-labelled DNA substrate with a 25 
bp double-stranded region and incubated at 37oC for 1 hour. Reactions were 
analysed by separating the dsDNA substrate and unwound single stranded a 
32P-labelled oligonucleotides using PAGE and exposing the gel to the 
phosphorimaging screen overnight. MMP Mcm complex (A) showed protein 
dependent helicase activity. (B) The helicase activity was quantified using 
densitometry. Boiled substrate was considered to displace DNA 100% in 
graphic values. 
 
The negative control was a reaction that did not contain protein while boiled 
substrate was a positive control.   
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could not be interpreted very well, as the concentration of MMP McmD was 
very low and it was also contaminated with a protein, which was probably 
the Cpn60 chaperone. As MMP McmD was expressed and purified from 
Arctic Express (DE3) RIL cells and these cells co-express the cold-adapted 
chaperonin Cpn60 at low temperature (Lund, 1994). These chaperonins 
confer improved protein processing at lower temperatures, potentially 
increasing the yield of active, soluble recombinant protein. 
 
4.4 Reaction conditions of helicase assays for M. maripaludis Mcms 
 
 
Co-purified MMP Mcm complex indicates that it forms a complex in vitro 
but it may be possible that a combination of homohexamers and 
heterohexamers were present within the purified MMP Mcm complex 
(Walters and Chong, 2010). As helicase activity of MMP McmA was quite 
strong (as discussed in section 4.3), it might be possible that it plays a major 
role in the helicase activity of MMP Mcm complex. Also the concentration 
of purified MMP McmA was 20 mg/ml and relatively purer then other MMP 
Mcms. For this reason, in further helicase assays MMP McmA was used. A 
number of different experiments were carried out to determine the optimum 
conditions for measuring helicase activity of this protein. 
 
4.4.1 Magnesium chloride and helicase assays 
 
Magnesium is an important component of helicase assays and without 
magnesium, unwinding is not possible (Costa et al., 1999). Helicase assays 
were performed in the presence of different magnesium chloride 
concentrations while the rest of the reaction conditions were the same as 
described in section 2.7.2. Unwinding was then quantified using 
densitometry on Quantity One software (Bio Rad). After quantification, the 
percentage values of DNA displaced were shown graphically (Figure 4.8) 
taking boiled substrate as 100% DNA displaced. 7 mM magnesium chloride 
gave the best results for helicase assays. This result is consistent with Costa 
et al., 1999 where they have shown in HDH VIII (human DNA helicase) 10 
mM is an optimal concentration for helicase assays. 
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Figure 4.8 Effect of magnesium chloride concentrations on helicase activity 
of MMP McmA: Representative gel (A) under increasing magnesium 
chloride concentrations shown protein dependent helicase activity. (B) The 
helicase activity was quantified using densitometry. Boiled substrate was 
considered to displace DNA 100% in graphic values. Error bars indicate 
standard error of the mean. The helicase activity of MMP McmA was 
measured under increasing magnesium chloride concentrations. The x-axis 
shows magnesium chloride concentrations while the y-axis shows the 
percentage of DNA unwound.  7 mM magnesium chloride was found to 
produce optimal unwinding activity over two protein concentrations. 
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4.4.2 Incubation period of helicase assays 
 
Helicase assays were carried out at the optimum temperature of 37 oC over 
20 minutes to 180 minutes for 15 nM and 60 nM protein concentrations. 
Maximum helicase activity was measured by densitometry of displaced band 
to occur in the reaction of 60 minutes. After quantification, the percentage 
values of DNA displaced were shown graphically. Error bars indicate 
standard error of the mean (Figure 4.9). 
 
4.4.3 pH range for helicase assays 
 
Helicase assays were performed at the temperature of 37 oC at different pHs. 
Three different concentrations of protein were used in these assays, which 
were 15 nM, 60 nM and 120 nM. The pH of helicase assay was maintained 
in the helicase buffer (Section 2.7.2). At pH 6 and pH 6.5, MMP McmA 
showed minimal unwinding. At pH 7.6 and pH 8, there was good 
improvement in unwinding efficiency.  There was a maximum of 12 fold 
increase in helicase activity due to increasing pH of reaction mixture. 
Maximum helicase activity was measured by densitometry for the reaction at 
pH 8. Error bars indicate standard error of the mean in the graph (Figure 
4.10). 
 
4.4.4 ATP concentration for helicase assays 
 
Helicase activity depends on the concentration of ATP. Without ATP, no 
unwinding can be detected (Costa et al., 1999).  These assays were 
performed at two protein concentrations, which were 15 nM and 60 nM. The 
rest of the reaction conditions were the same as described in Materials and 
Methods section 2.7.2. ATP concentrations used in these assays were 2 mM, 
4 mM, 6 mM, and 8 mM. Maximum unwinding activity was measured with 
the 6 mM ATP (Figure 4.11). Above 6 mM ATP, there was a decrease in the 
efficiency of unwinding. There is precedence for the increased ATP 
concentrations having an inhibitory effect on unwinding (Costa et al., 1999). 
Although from 2 mM to 6 mM maximum  increase in  helicase  activity  was  
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Figure 4.9 Effect of incubation duration on helicase activity of MMP 
McmA: The helicase activity of MMP McmA was measured over increasing 
time periods from 20 minutes to 180 minutes (A). The x-axis showed the 
increasing time period while the y-axis shows the percentage of DNA 
unwound (B).  60 minutes incubation shows maximum helicase activity for 
MMP McmA. There is a possibility that over a time after 60 minutes, DNA 
could be re-annealed in a reaction mixture. 
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Figure 4.10 Effect of pH on helicase activity of MMP McmA: The helicase 
activity of MMP McmA was measured over pH range from 6 to 8. 
Representative gel (A) under increasing pH range showed increasing 
helicase activity from 6 to 8. (B) The helicase activity was quantified using 
densitometry. The x-axis shows the increasing pH range while the y-axis 
shows the percentage of DNA unwound. Mcm McmA at pH 8 displays the 
highest level of DNA helicase activity for MMP McmA. 
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Figure 4.11 Effect of ATP concentrations on helicase activity of MMP 
McmA: Representative gel (A) under increasing ATP concentrations shown 
protein dependent helicase activity. (B) The helicase activity was quantified 
using densitometry. The x-axis shows an increasing concentration of ATP 
while the y-axis shows the percentage of DNA unwound.  Maximum 
helicase activity was detected at 6 mM ATP concentration for both 
concentrations. 
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found to be between 2 fold to 3 fold. 
 
4.4.5 Effect of different salts and their concentration on helicase assays 
 
Recent reports describe a significant effect of anions on Mcm helicase 
activity. More specifically this study suggested that chloride inhibits DNA 
unwinding by Mcms whereas glutamate supports Mcm helicase activity 
(Bochman and Schwacha, 2008). Therefore further investigation included 
the effect of other salts and their concentrations on unwinding ability of 
MMP McmA.   The helicase activity of MMP McmA was detected in the 
presence of different salts and then quantified using densitometry. 15 nM 
and 60 protein concentrations were used to test the effect of different salts on 
unwinding. Sodium glutamate, potassium glutamate and sodium chloride 
were the salts to test on unwinding efficiency. Three different concentrations 
of each salt  (150 mM, 400 mM, 600 mM) were tested. The rest of the assay 
was the same as described in Material and Method section 2.7.2. From the 
results, it was obvious that sodium chloride inhibited helicase activity and, 
sodium and potassium glutamate enhanced the activity (Figure 4.12) which 
further indicates that glutamate positively effects helicase activity while 
chloride inhibits helicase activity; this result is consistent with the recently 
published work discussed above. 
 
4.5 Discussion 
 
Although the purified MMP Mcm complex was available in the Chong lab, 
the concentration of complex was very low (0.258 mg/ml). Trials were 
conducted to purify co-expressed pairs of M. maripaludis Mcms protein. 
MMP McmA and MMP McmC were purified efficiently in a single step. 
MMP McmB and MMP McmD were purified in first step of GST affinity 
purification but the purified protein was not pure and additional lower 
molecular weight proteins were present. Also the concentration of MMP 
McmD was very low in affinity chromatography. To get rid of low 
molecular weight proteins, an additional step of anion exchange 
chromatography was carried out. In anion  exchange  chromatography, MMP  
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Figure 4.12 Effect of different salts and their concentrations on helicase 
activity of MMP McmA: The helicase activity of MMP McmA was 
measured in the presence of different salts and then quantified using 
densitometry. Three different salts (A) potassium glutamate, (B) sodium 
glutamate (C) sodium chloride were tested for their possible role in DNA 
unwinding. (D) The x-axis shows the increasing concentration of salts (150 
mM, 400 mM, 600 mM) while the y-axis shows the percentage of DNA 
unwound (D). Shades of one colour represent the effect of one salt on 
different concentrations of protein.  Consistent with published data sodium 
chloride inhibits helicase activity while sodium and potassium glutamate 
enhanced helicase activity. 
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Sodium glutamate (Blue) 
Potassium glutamate (Green) 
Sodium chloride (Pink) 
 
Figure 4.12 Continued 
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McmB was eluted without any other contaminating proteins but MMP 
McmD was lost. But overall, concentrations of MMP Mcms (A, B and C) 
proteins were greatly enhanced by this method of purification. It was then 
decided to perform helicase assays on the available MMP Mcms. 
 
Individual purified M. maripaludis Mcms proteins and complex were used to 
carry out helicase activity assays. Individually MMP McmA and MMP 
McmB showed robust protein dependent unwinding activity. MMP McmC 
did not display any helicase activity, while MMP Mcm complex (includes 
Mcms, A, B, C and D) also showed good helicase activity. MMP McmD was 
mainly contaminated and low in concentration, therefore helicase activity 
results from MMP McmD were largely non-informative. It is very 
interesting that although McmA is very similar to McmB and McmC in 
sequence but still showed more robust activity compared to McmB while 
McmC did not show any activity under same conditions. As MMP McmA 
efficiently unwound DNA substrate, therefore this protein was further used 
to find out optimum reaction conditions for unwinding. Magnesium chloride 
concentration is crucial for DNA unwinding, without magnesium chloride 
unwinding is not possible but at the same time high concentrations of 
chloride can inhibit unwinding. The optimum concentration found was 7 
mM. Experiments to determine the best incubation period for unwinding 
suggested that 60 minutes of incubation gives best results. Furthermore the 
pH of helicase buffer used in unwinding also gives important insight. At 
lower pH, a low amount of DNA unwinding was measured. At pH 7.6 and 
pH 8.0, unwinding efficiency was very good. Helicase activity also depends 
on ATP in the reaction mixture. Without ATP, no helicase activity is 
possible. 6 mM ATP produced maximum unwinding and above this 
concentration, ATP inhibited helicase activity. The effect of different salts 
and their concentration on unwinding was also measured. Sodium chloride 
inhibited helicase activity and, sodium and potassium glutamate enhanced 
the activity which further indicates that the glutamate positively affects 
helicase activity while chloride inhibits helicase activity. 
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Chapter 5: The role of potential kinases in replication in archaea 
 
 
5.1 Introduction  
 
Although archaeal metabolism and operonic gene organization is certainly 
more similar to prokaryotic eubacteria, the archaeal factors for transcription, 
translation and DNA replication are more similar to those found in 
eukaryotes (Vas and Leatherwood, 2000). Most archaea replicate their 
circular genome from a single DNA replication origin as do bacteria, even 
though they may use eukaryotic-like proteins to do so (Myllykallio at al., 
2000). For timely replication of big genomes in eukaryotes, it is important 
for replication to be started at multiple replication origins simultaneously. To 
coordinate replication initiation at various sites, there is a need for regulation 
that is in part carried out by cyclin-dependent kinases (Cdks) and cyclins 
(see reviews by Morgan, 1995; Roberts, 1999; Sherr and Roberts, 1999). 
Eukaryotic replication is also dependent on the replication specific kinase 
Cdc7-Dbf4 (Sclafani, 2000). Archaeal genomes are smaller and do not need 
as much coordination but archaea still need to couple replication with growth 
and division. Most archaea allocate less then 0.5% of their genome to signal 
transduction molecules (Galperin, 2005) compared to 4% in eukaryotes for 
kinases and phosphatases (Manning at al., 2002a and Manning at al., 2002b). 
Archaea lack recognizable homologues of cyclin dependent kinases, cyclins, 
or the kinase Cdc7.  
 
Another reason to focus on kinases is that recently Dr Alison Walters in the 
Chong group co-precipitated MMP0004 together with MMP McmA 
(unpublished data, Chong lab). Bioinformatics studies give powerful 
information of particular proteins and their function. Based on sequence 
analysis studies, we tried to find the role of this hypothetical archaeal protein 
from Methanococcus maripaludis strain S2 (MMP0004). Another protein 
from Methanocaldococcus jannaschii strain DSM 2661 (Mj1073) that has 
91% sequence homology with MMP0004 was also cloned and purified in 
order to examine the potential role of these proteins in replication of archaea. 
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5.2 Bioinformatics of M. maripaludis (MMP) 0004 and M. jannaschii 
(Mj) 1073 
 
5.2.1 MMP0004 
 
MMP0004 is a hypothetical protein that contains 298 amino acids and 
belongs to the RIO kinase family. RIO kinases are atypical protein serine 
kinases containing a kinase catalytic signature, but otherwise show very little 
sequence similarity to typical PKs (Angermayr et al., 2000). Serine kinases 
catalyze the transfer of the gamma-phosphoryl group from ATP to serine 
residues in protein substrates (Edelman et al., 1987). RIO2 is present in 
archaea and eukaryotes (Manning et al., 2002). The N-terminal domain 
found in RIO2 kinases is structurally homologous to a wHTH domain. It 
adopts a structure consisting of four alpha helices followed by two beta 
strands and a fifth alpha helix (LaRonde-LeBlanc and Wlodawer, 2004). The 
wHTH domain is primarily seen in DNA-binding proteins, although some 
wHTH domains may be involved in RNA recognition. RIO2 is essential for 
survival and is necessary for rRNA cleavage during 40S ribosomal subunit 
maturation (Vanrobays et al., 2001). The biological substrates of RIO2 are 
still unknown (Campbell and Karbstein, 2010). 
 
5.2.2 Mj1073 
 
 
Mj1073 belongs to the RIO-type serine/threonine-protein kinase family. The 
BLAST searches showed that the similarity between MMP0004 and Mj1073 
is 91%. From the protein database, it is shown to have metal binding, ATP 
binding and serine/threonine-protein kinase motifs. This protein belongs to a 
heterogenous group of serine/threonine protein kinases that are either non-
specific or their specificity has not been determined to date but there is 
automated prediction of optimal substrate prediction available that use 
crystal structures, molecular modelling, and sequence analyses of kinases 
(Brinkworth et al., 2002). The functions associated with different regions of 
the protein and their corresponding amino acid positions according to 
bioinformatics studies are summarised in table 5.1 along with a cartoon 
representation (figure 5.1) of different features on sequence. 
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Table 5.1 Function of different regions of Mj1073 gene. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Cartoon representations of important regions and sites on Mj1073 
gene sequence. 
 
Feature Key Position (s) 
Amino 
acids 
Length 
Amino 
acids 
Description 
Molecular Processing 
Chain 1-270 270 RIO-type 
serine/threonine-protein 
kinase Rio2 
Regions 
Domain 65-270 206 Protein kinase 
Nucleotide binding 72-77 6 ATP 
Nucleotide binding 158-164 7 ATP 
Nucleotide binding 206-207 2 ATP 
Sites 
Active site 202 1 Proton accepter 
Metal binding 76 1 Magnesium 1 
Metal binding 207 1 Magnesium 2 
Metal binding 220 1 Magnesium 1 
Metal binding 220 1 Magnesium 2 
Binding site 93 1 ATP 
Binding site 20 1 ATP 
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5.3 Phylogenetic analysis  
 
Phylogenetic analysis was carried out on MMP0004 in order to find the 
closest homologues.  The closest homologues of MMP0004 were found in 
Methanocaldococcus jannaschii and Methanothermococcus okinawensis 
(Figure 5.2). There are homologues of this protein present in lower 
eukaryotes and in yeast as well. Outside the Methanococcales, there is less 
homology.  Although it is a hypothetical protein, the BLAST searches match 
this protein to other serine/threonine protein kinases that predict its role as a 
kinase. 
 
5.4 Protein structure prediction 
 
The prediction of the three-dimensional structure of a protein from its amino 
acid sequence was carried out using protein structure prediction software 
that include RaptorX (Peng and Xu, 2011), SWISS-MODEL (Guex and 
Peitsch, 1997; Schwede et al., 2003; Arnold et al., 2006) and M4T 
(Fernandez-Fuentes et al, 2007). These models are based on trying to fit the 
protein sequence to the most related structure available in the database.  In 
MMP0004 and Mj 1073 case, this is the protein database (pdb) structure of 
1zao, which is A. fulgidus RIO2 Kinase.  It should be noted that this protein 
is quite distant compared to other available sequences as illustrated in figure 
5.2. The generated model of MMMP0004 was evaluated by using QMEAN4 
score in SwissModel Workspace. The global QMEAN4 scoring function 
(Benkert et al. 2008) is a linear combination of structural descriptors using 
statistical potentials. QMEAN4 is a reliability score for the whole model that 
can be used in order to compare and rank alternative models of the same 
target. This score is a composite score consisting of a linear combination of 
four statistical potential terms. The quality estimate ranges between 0 and 1 
with higher values for better models. The QMEAN4 value for MMP0004 
structure is 0.5 (Figure 5.3 A). Residue error plot showed two big error 
peaks (Figure 5.3 B) and rest of the plot seems fine and does have conserved 
residues (discussed later). 
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Figure 5.2 MMP0004 phylogenetic tree: A multiple sequence alignment  
shows that there is homology of MMP0004 with other proteins present in 
other archaea and lower eukaryotes. The closest homology is in 
Methanocaldococcus jannashii and Methanothermococcus okinawensis. 
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Figure 5.3 QMEAN4 score and residue error plot of MMP0004: QMEAN4 
score (A) of MMMP0004 was evaluated by using SwissModel Workspace 
and 0.5 value of QMEAN score is obtained that lies exactly in the middle. 
Residue error plot (B) showed two big error peaks indicating regions of 
dissimilarity when compared to A. fulgidus RIO2 Kinase. 
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A number of structures of protein-serine/threonine and protein-tyrosine 
kinases have been determined, and the conserved subdomain residues have 
been shown to be involved in recognition and binding of ATP or substrate 
peptides, as well as in actual catalysis (Bossemeyer, 1995; Engh and 
Bossemeyer, 2002; Knighton et al., 1991a, 1991b). The predicted ribbon 
structures also have a specific ATP binding pocket that is conserved in all 
serine/threonine kinases. Predicted structures of both proteins (MMP0004 
and Mj1073) are shown in figure 5.4 with the highlighted yellow residues on 
MMP0004 that may have role in DNA binding. Analysis of the structure of 
A. fulgidus (Af) RIO2 kinase revealed the presence of two domains, the N-
terminal domain and the C-terminal domain (LaRonde-LeBlanc and 
Wlodawer, 2004).  The two model structure of MMMP0004  (5.4 A) and 
Mj1073 (5.4 B) and the crystal structure A. fulgidus (Af) RIO2 Kinase (5.4 
C) seems essentially the same. The N-terminal domain (wHTH domain) 
contains a combination of α helices and β strand in all three structures. 
Middle part of the ribbon structure is the same in all three proteins, that is 
five β strands with one long α helix. The C-terminal domain (RIO kinase 
domain) is the most different part in all three proteins as the number of β 
strands are different in all three proteins 
 
5.4.1 Comparison of the wHTH domain with its structural equivalance  
 
A multiple sequence alignment of the MMP0004 homologues from archaea  
showed that all these proteins possess the motifs believed to be important in 
kinase function (Figure 5.5 and 5.6). 
 
The N-terminal domain is conserved in members of the Rio2 family. A 
strand that connects the second and third α helices combines with the other 
two β strands to form a β sheet, and the loop between the second and third β 
strands is called a “wing,” which gives the wHTH its name. The fifth α helix 
replaces the second wing seen in some proteins with the wHTH fold 
(LaRonde-LeBlanc and Wlodawer 2004). The most commonly reported 
function of such domains is DNA binding (Gajiwala et al., 2000; Gajiwala 
and  Burley,  2000).   From  the  predicted   structural  data  (Figure 5.4)  and 
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Figure 5.4 Overall structures: Predicted ribbon structures of  MMP0004 (A) 
and Mj1073 (B) and  crystal structure of  A. fulgidus Rio2 (C). α Helices are 
shown in green colour while β Sheets are pink in colour in A and B. 
MMMP0004 model was generated in SwissModel while Mj1073 is 
regenerated from RaptorX while the crystal structure of A. fulgidus Rio2 was 
taken from LaRonde-LeBlanc and Wlodawer, 2004. 
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sequence alignment of the N- terminal domain  (Figure 5.5), it is clear that 
the MMP0004 protein is missing one α helix named as α0 while Mj1073 is 
missing two α helices namely α0 and α1. Similarly there are three β strands 
present in Af. Rio2, this is not the case with MMP0004 and Mj1073, they 
both are missing one β strand and most probably that is one called β3 (Figure 
5.5). One possible reason might be that a few residues are missing from this 
segment in the alignment and also this sequence does not contain any 
homology with any residue with A. fulgidus Rio2. 
 
5.4.2 The RIO kinase domain  
 
The C-terminal RIO2 domain, the sequence of which is conserved in both 
Rio1 and Rio2 proteins, is indeed structurally homologous to known protein  
kinase domains (LaRonde-LeBlanc and Wlodawer, 2005a, b). It is bilobal 
with a twisted five-stranded β sheet and a single long α helix (αC) in the N-
terminal lobe whereas the C-terminal lobe consists of a combination of four 
β strands and three α helices (Figures 5.4 C and 5.6) in the case of A. 
fulgidus Rio2. The N-terminal lobe of RIO kinase domain in MMMP0004 
and Mj1073 is exactly the same as Af. Rio2 in predicted structures but the C-
terminal lobe consists of two β strands and four α􏰁helices incase of 
MMP0004 (Figures 5.4 A and 5.6). and three α helices but no β strands in 
Mj1073 predicted ribbon structures (Figures 5.4 B and 5.6).  
 
A loop of amino acids between β strand 3 (β3) and α helix 􏰁C  (αC) contains 
a highly conserved threonine in all three of these proteins, possible targets 
for phosphorylation (Figure 5.6). 
 
5.4.3 Conserved residues of the RIO proteins 
 
The structure of Rio2 from A.fulgidus was analyzed to locate the residues 
that were conserved in the RIO protein family and when mapped on the 
surface, the conserved residues appeared to cluster around the active site on 
one face of the protein (LaRonde-LeBlanc and Wlodawer, 2004) and 
included the   following   residues. Tyr222 was conserved as either a Tyr or a  
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Figure 5.6 The RIO kinase domain: Sequence alignment of the kinase 
domains of Rio2 from A. fulgidus (AfRio2), M. maripaludis (MMMP0004) 
and M. jannaschii (Mj1073). Schematics of the secondary structure are 
shown in blue (Rio2). Residues highlighted in red are identical in AfRio2, 
MMP0004 and Mj1073. Residues highlighted in green are identical in 
MMP0004 and Mj1073 but not in AfRio2. Phe and Tyr are colored as 
identical in all cases. Kinase subdomains based on LaRonde-LeBlanc and 
Wlodawer, 2004 are indicated with black Roman numerals.  
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Phe (β3).  Glu103 was located in the glycine-rich loop (β1) and is conserved 
in all RIO proteins. Lys102 (β1) was also conserved in all RIO domains but 
did not interact with the nucleotide and was disordered in the structure. The 
disordered loop (residues 125–141, between β3 and αC) was located near the 
conserved surface and contained Gly125, Thr127 and Tyr148, all of them are 
highly conserved among Rio2 family members including MMP0004 and 
Mj1073 (Figure 5.6). 
 
5.5 Possible protein/protein interactions 
 
Furthermore MMP0004 protein sequence was analysed in other 
bioinformatics studies for its possible interactions with other proteins within 
M. maripaludis S2 strain.  For this purpose online the string database was 
used. STRING is a database of known and predicted protein interactions 
(www.string-db.org.). The interactions include direct (physical) and indirect 
(functional) associations. With a medium confidence level (score 0.400), 
MMP0004 shows predicted interactions with a number of different proteins 
that are either hypothetical or uncharacterised proteins. With a high level of 
confidence (score 0.700), MMP0004 interacts with 30s ribosomal proteins 
(Figure 5.7). The activity of Rio2 is necessary for rRNA cleavage in 40S 
ribosomal subunit maturation. The interaction of MMP0004 with ribosomal 
proteins, justifies its role as a serine/threonine kinase of the RIO2 family 
because the RIO2 family is necessary for rRNA cleavage. The network of 
interacting proteins generated is with medium confidence level (Figure 5.7). 
It is interesting that no interaction has been shown with any of the Mcms as 
Dr Alison Walters in the Chong group recently showed that the MMP 
McmA interacts with MMP0004 in vivo (unpublished data, Chong lab). 
 
5.6 Cloning of MMP0004 
 
 
The MMP0004 gene was cloned from genomic DNA of M. maripaludis S2 
available in the Chong lab. The MMP0004 gene was amplified via touch 
master mixture instead of Taq polymerase. The PCR product was first 
cleaned using QIAquick  PCR clean-up  kit (QIAGEN) and blunt ligated into 
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Figure 5.7 Possible interaction of MMP0004: In vivo interaction of 
MMP0004 with other proteins within M. maripaludis S2. Most of the 
interactions are with ribosomal proteins. No interaction has been shown with 
any of the Mcm. Thicker lines represent stronger associations. 
http://string-db.org/ 
 
 
 
 136 
down PCR using primers containing appropriate restriction sites (see 
appendix  2  for primer   details). FideliTaq   DNA  polymerase  was  used in 
cloning vector pJET 1.2 following manufacturer’s protocol. After various 
failed trials of subcloning MMP0004 into an expression vector from pJET 
1.2, MMP0004 was subcloned into another holding vector pGEM®-T using 
manufacturer’s protocol. The resulting vector and pET 19b were digested 
with BamH1 and Xhol and ligated overnight at 4 oC. To confirm the ligation 
had worked, pET 19b containing MMP0004 was digested (Figure 5.8). pET 
19b construct containing MMP0004 was sent for sequencing to the 
sequencing laboratory of York University (Technology Facility). 
Transformation was carried out using E.coli BL21 (DE3) Rosetta competent 
cell. In transformation protocol LB was used instead of SOC media.  
 
5.7 Expression of MMP0004 
 
MMP0004 was expressed in 750 ml culture which yielded 4 gram of pellet. 
Cells, which were harvested by centrifugation, resuspended immediately in 
resuspension buffer (Section 2.5.1) before storing at -80 oC prior to protein 
purification. 
 
5.8 Purification of MMP0004 
 
 
Resuspended cells stored at  -80 oC were thawed on ice and protein was 
purified in the same way as explained in section 2.5. Elution fraction 
samples were run on 15% SDS-PAGE as the size of this protein was small. 
Eluant fractions were pooled together and flash frozen in liquid nitrogen and 
stored at -80 oC. SDS-PAGE analysis showed clean and intense band at 
expected size (29.9 KDa) just above 25 KDa protein marker (Figure 5.9). 
Purified proteins were quantified using Bradford assays. The concentration 
was 3.3 mg/ml in a volume of 15 ml. The purified protein was concentrated 
as explained in section 2.9.7 in Materials and Methods. 
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Figure 5.8 Restriction digestion of pET 19b containing MMP0004: 5 µg of 
DNA was digested over the period of 1 hour at 37 oC and loaded in three 
lanes of 2% agarose gel in TAE along with uncut vector of pET 19b. The 
agarose gel showed that MMP0004 (897 bp) was ligated into pET 19 b 
(5717 bp). 
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Figure 5.9 Purification of MMP0004: SDS-PAGE analyses of fractions from 
purification trials of MMP0004. Protein was expressed in E.coli BL21 (DE3) 
cells Rosetta at 37 oC overnight. Pellets from 750 ml of culture were 
resuspended, and the soluble protein fraction was bound, washed and eluted 
from nickel beads using 500 mM imidazole. A band of ~30 KDa was present 
in elution fraction visible after Coomassie blue staining. Protein ID was 
confirmed by mass spectrometry (MS). 
TP, total protein; UB, unbound fraction; EF, elution fraction 
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5.9 Kinase assays for MMP0004 
 
The protein database available on the NCBI website showed that MMP0004 
is a putative protein serine/threonine kinase. Kinase assays were used to test 
whether MMP0004 acts as Mcm kinase. As the substrates for MMP0004 
were unknown and MMP0004 has been pulled down together with MMP 
McmA from M. maripaludis extracts (unpublished data, Chong lab), it was 
hypothesized that the substrate for MMP0004 was Mcms. Kinase activity 
assays were carried out to test the phosphorylation on purified MMP McmA 
by MMP0004. MMP McmA was used instead of MMP Mcm complex as the 
purity and concentration of MMP McmA was much higher then MMP Mcm 
complex. Also MMP McmA showed robust helicase activity as discussed in 
previous chapter. The results from the kinase assays showed that there was 
not any phosphorylation by MMP0004 on MMP McmA. It may be due to 
substrate choice or requirement for other proteins or cofactors in these 
assays. The gel picture was not good quality (not shown), as the γ[32P]ATP 
required 4-12 % gradient gel that was not available. Instead the samples 
were run on 12% TBE gel that made the whole gel picture black. 
 
Further to confirm results of kinase activity of MMP0004 on McmA, 
helicase assays were carried out on kinase treated McmA. The helicase assay 
carried out on McmA is described in section 2.7.2. Interestingly McmA did 
not show any helicase activity after being included in kinase assay with 
MMP0004. The positive control was the boiled substrate while the negative 
control was substrate without any protein added (Figure 5.10). There may be 
the possibility that McmA proteolysis took place in kinase assays and then 
further in helicase assays, and that may be the reason it did not show any 
helicase activity afterwards. 
 
5.10 Cloning of Mj1073 
 
 
The Mj1073 gene from DSM 2661 strain was cloned from the whole 
genomic DNA of Methanocaldococcus jannaschii present in the Chong lab. 
The Mj1073  gene  was  amplified  using  touch  down   PCR   with   primers  
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Figure 5.10 Helicase activity of kinase treated MMP McmA: PAGE analysis 
of strand displacement assays of kinase treated MMP McmA with various 
protein concentrations. Controls were generated by performing the helicase 
assays with intact substrate (negative control) and by boiling substrate 
(positive control). Kinase-treated MMP McmA did not show any helicase 
activity. 
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containing appropriate restriction sites (see appendix 2 for primer details). 
The method of cloning of Mj1073 was essentially the same as MMP0004 
explained in section 5.2.2 except the initial annealing temperature of primers 
for Mj1073 was quite low (46 oC). PCR product was first cleaned using 
QIAquick PCR clean-up kit (QIAGEN) and blunt ligated into cloning vector 
pGEM®-T. The resulting vector and pET 19b were prepared in a similar 
manner with BamH1 and Xhol restriction sites and ligated overnight at 4 oC. 
2 µl of ligation mix was transformed into Rosetta DE3 E.coli competent 
cells. To confirm the ligation has worked, digested the pET 19b containing 
Mj1073 (Figure 5.11). Sequencing laboratory of York University 
(Technology Facility) confirmed the sequence of Mj1073 in pET 19b 
without any mutation. Transformation was carried out using E.coli BL21 
(DE3) Rosetta competent cells. 
 
Making glycerol stocks was not possible as storing these cells at -80 oC did 
not yielded much protein and resulted in the loss of plasmid, so direct 
purification step was taken for this protein from fresh transformation every 
time. 
 
5.11 Expression of Mj1073  
 
Mj1073 was expressed in 750 ml culture which yielded 3 grams of pellet. 
Cells, which were harvested by centrifugation, resuspended immediately in 
resuspension buffer (Section 2.5.1) before storing at -80 oC prior to protein 
purification. 
 
5.12 Purification of Mj1073 
 
The protocol for the purification of Mj1073 protocol was essentially the 
same  as  for  MMP0004  (Section 5.8).  Eluted fraction samples were run on 
15% SDS-PAGE and protein was visualised using Coomassie blue staining. 
Elution fraction 1 and 2 displayed a pure band of Mj1073 at the expected 
size of 27 KDa (Figure 5.12). Purified proteins were quantified using 
Bradford  assays.  The  concentration  was 5.1 mg/ml   in a volume of 12 ml.  
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Figure 5.11 Restriction digestion of pET 19b containing Mj1073: 5 µg of 
DNA was digested over the period of 1 hour at 37 oC and loaded in three 
lanes of 2% agarose gel in TAE along with uncut vector of pET 19b. The 
agarose gel showed that Mj1073 (810 bp) was ligated into pET 19 b (5717 
bp). 
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Eluant fractions were pooled together and flash frozen immediately in liquid 
nitrogen then stored at -80 oC. 
 
5.13 Discussion 
 
MMP0004 protein has been identified in Methanococcus maripaludis S2 as 
possibly interacting with Mcms. The role of MMP0004 has been suggested 
to be a kinase by bioinformatics studies based on its sequence homology 
with other serine/threonine kinases. The study of this protein in relation to 
Mcm leads to the hypothesis that this protein may act as a kinase using Mcm 
as a substrate. As this protein is hypothetical, and the only role that was 
assigned to it was as a putative kinase by BLAST searches, the substrates for 
this kinase are not known. The closest homology of this protein was present 
in Methanocaldococcus jannaschii (Mj1073). Predicted ribbon structures 
were obtained from different online data servers and all produced similar 
structures that were based on the most homologus known protein crystal 
structure of A. fulgidus RIO2 kinase. Both of these proteins are fairly small, 
comprising of 29 KDa and 27 KDa for MMP0004 and Mj1073 respectively. 
Mj1073 is likely to be more thermostable as M. jannaschii is an 
hyperthermophilic organism (Bult et. al., 1996). Both proteins were cloned 
and purified. Purified MMP0004 was further subjected to kinase assays but 
did not phosphorylate MMP McmA. Either MMP0004 does not use McmA 
as a substrate or it requires other proteins or cofactors to be present to 
produce kinase activity. It is also possibe that it does not have any kinase 
activity but the helicase assays of kinase-treated MMP McmA did not show 
any DNA unwinding activity. MMP McmA did show helicase activity under 
normal circumstances as described in the previous chapter. As the substrate 
for Mj1073 was unknown, so the kinase assays for Mj1073 were not 
performed. But both proteins were successfully purified and can be used in 
future for the identification of their role and further insight to the kinase 
activity related to these proteins. 
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Figure 5.12 Purification of Mj1073: SDS-PAGE analyses of fraction from 
purification trials of Mj1073. Protein was expressed in E.coli BL21 (DE3) 
Rosetta cells at 37 oC overnight. 500 ml culture pellet was resuspended 
bound, washed and eluted from nickel bead using 500 mM imidazole. A 
band just above 25 KDa marker is visible at the expected size for Mj1073 
(27KDa). 
 
UI, uninduced; TP, total protein; SF, soluble fraction; UB, unbound fraction; 
EF, elution fraction 
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Chapter 6: Discussion 
 
6.1 Reconstitution of hMcm2-7 complex 
 
The minichromosome maintenance proteins are components of the 
prereplicative complex (preRC) that assembles on replication origins prior to 
S phase (Donovan et al., 1997; Tanaka et al., 1997). The six proteins Mcm2-
7 form a heterohexameric ring that is the replicative helicase in eukaryotic 
cells (Schwacha and Bochman, 2008). Mcm proteins are required for 
replication initiation and elongation (Labib et al., 2000; Lei and Tye, 2001). 
In addition, they appear to travel with the replication fork in vivo (Aparicio 
et al., 1997). All six of the Mcm proteins are required for ongoing replication 
in S. cerevisiae (Labib et al., 2000). The purification of yeast Mcm2-7 as 
individual subunits by expressing individually in bacteria was reported 
(Davey et al., 2003). Recombinant individual human Mcm2-7 were 
expressed in E.coli in this study. It was not possible to obtained individual 
hMcm2-7 in purified form to conduct further assays.  Only hMcm4, 6 and 7 
were obtained in low concentrations after a number of different purification 
trials. Mcm4, 6 and 7 were used further to assemble a complex without 
success. hMcm2 was purified in very small amounts by expressing it at low 
temperature in Arctic Express (DE3) RIL cells. Despite various efforts to 
purify hMcm3 and 5, they remained largely insoluble.  
 
At that point it was decided to try to co-express and co-purify all hMcms 
from E.coli. All six hMcms were co-purified through four purification steps 
successfully when co-expressed in E.coli, suggesting that they form a 
heterohexameric complex (Lee and Hurwitz, 2000; Davey et al., 2003). 
However the complex concentration was low and only sufficient to perform 
further activity assays but for stoichiometric analysis, the complex needed to 
be pure and more concentrated. Therefore stoichiometry of the 
heterohexameric complex was not ascertained. Quantification of the hMcm 
complex would be possible by using MALDI-MS fingerprinting if there 
would be equal abundance of all hMcm in final purification step with no 
degradation or contamination. For these reasons it was decided not to use 
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this complex for stoichiometric studies that remains an area of speculation as 
the stoichiometry of hMcm complex has not been measured accurately to 
date because it has been dependent on indirect method of antibody detection. 
All six proteins were present in the last chromatographic step as shown by 
western blot, but the amount of each protein was not equal as the intensity of 
different bands of each hMcm varied in SDS PAGE Although SDS PAGE 
and western blots indicated the presence of all six hMcms, after various co-
purification steps, but there may be some protein degradation products 
visible in SDS PAGE. It is quite possible that the purified complex is a 
mixture of homohexamers and heterohexamers with various combinations as 
Mcms are isolated in various stable assemblies (Davey et al., 2003).  
 
Another possibility is that they may not be forming heterohexamers and the 
complex is just a number of different homohexamers. As the protein 
complex is pull down with his-tag that was present on three of the proteins, 
that confirms Mcm2-7 protein complex do consists three dimers but does not 
confirm if the hMcm complex actually makes a heterohexamer containing all 
six of the hMcms. If the approach of co-purifying the hMcm with S-tag or 
GST-tag or Txr tag would have followed instead of his-tag, it would have 
confirmed whether they all make heterohexamers as these tags were present 
only on one of the hMcms.  
 
In future this complex can be readily characterised further by electron 
microscopy to provide a three-dimensional reconstruction. 
 
6.2 hMcm helicase 
 
In eukaryotes, in vivo observations implicate the Mcm2-7 complex as the 
replicative helicase (reviewed in Bell and Dutta, 2002) but, yeast Mcm2-7 
has been reported to lack in vitro helicase activity (Bochman and Schwacha, 
2007). Interestingly, both an archaeal Mcm complex (reviewed in Kelman 
and White, 2005) and hexameric Mcm complex containing only three of the 
six eukaryotic Mcm subunits (Mcm4/6/7 complex) had DNA-unwinding 
activity (Ishimi, 1997; Kelman et al., 1999; Chong et al., 2000; Lee and 
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Hurwitz, 2001; Kaplan et al., 2003). The purified Cdc45/Mcm2-7/GINS 
complex was shown to associate with an active ATP-dependent DNA 
helicase function (Moyer et al., 2006). This discrepancy that Mcm2-7 lacks 
helicase activity was rationalized and Mcm2-7 complex from yeast was 
shown to have anion dependent helicase activity (Bochman and Schwacha, 
2008). Very recently a single subunit of Mcm6 was isolated from pea and 
reported to form a homohexamer and function as a DNA helicase (Tran et 
al., 2010). To date no study of human Mcm2-7 complex has shown helicase 
activity. Purified hMcm2-7 complex was subjected to helicase activity 
assays in this study. Robust in vitro helicase activity of hMcm2-7 complex 
was confirmed by strand displacement assays. This result of hMcm2-7 
complex having helicase activity is consistent with recently published papers 
(Bochman and Schwacha, 2008). More specifically Bochman and Schwacha 
demonstrated that chloride ions inhibit DNA unwinding by Mcms whereas 
glutamate ions support Mcm helicase activity (Bochman and Schwacha, 
2008). Although in this study we have shown that the presence of chloride 
does decrease Mcm helicase activity but does not abolish it completely (See 
later). The anions present in previously published helicase assays would 
have blocked Mcm2-7-unwinding activity. This study further confirms that 
there is no need for any other proteins or cofactors for helicase activity of 
hMcm2-7 although it has been previously shown that purified Cdc45 and 
GINS are necessary for Mcm2-7 helicase activity in a complex purified from 
Drosophila (Moyer et al., 2006). Although this study does not preclude the 
possibility that their presence may increase the helicase activity or even 
processivity of helicase activity. 
 
To further confirm that hMcm2-7 has in vitro helicase activity, it would have 
been clear if there were any doubt, if the elution fraction that does not 
contain any hMcm2-7 protein in it (after the hMcm2-7 comes off), would 
have been assayed for helicase activity in parallel with the elution fraction 
that does actually contain hMcm2-7. This would have confirmed that 
nothing in the reaction mixture or elution fraction is driving the helicase 
activity except hMcm2-7 complex. 
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Along with the hMcm2-7 complex, hMcm4, hMcm6, hMcm7 could have 
been individually tested for helicase assays as a single subunit of Mcm6 has 
been reported to form a homohexamer and function as a DNA helicase (Tran 
et al., 2010). 
 
6.3 Phosphorylation of hMcm2-7 
 
The hMcm complex was further tested as a target for kinase activity in the 
presence of CDK2/Cyclin A and CDK2/Cyclin E. Human Mcm2-7 complex 
showed phosphorylation with both complexes, CDK2/cyclin A and 
CDK2/cyclin E. CDK2/cyclin E showed more robust activity compared to 
CDK2/cyclin A. Various previous studies confirmed the phosphorylation of 
individual Mcms and Mcm2-7 complex by CDK (Ishimi and Komamura-
Kohno, 2001; Wheeler et al., 2008). The site(s) of phosphorylation by 
CDK2/Cyclin A and CDK2/Cyclin E are not fully known. It has been 
demonstrated recently that Mcm3 is a substrate of cyclin E/Cdk2 and can be 
phosphorylated by cyclin E/Cdk2 at Thr722 (Li et al., 2011). Cdk2/cyclin A 
and Cdc2/cyclin E might be phosphorylating at the same or different sites, 
however it suggests that both Cdk2/cyclin A and Cdk2/cyclin E have similar 
specificity of substrate recognition, as both of them are phosphorylating the 
hMcm complex at various sites. Although it seems likely Cdk2/cyclin E has 
more sites for phosphorylation compared to Cdk2/cyclin A due to the signal 
strength observed in kinase assays.  
 
Using mass spectrometry, phosphorylation sites of the human Mcm complex 
could have identified but due to PhD time frame as a limiting factor, samples 
were not sent for mass spectrometry. This could be done in future to identify 
known and novel phosphorylated sites on each of the hMcm.  
 
6.4 Helicase activity of phosphorylated hMcm2-7 
 
Phosphorylated hMcm2-7 via CDK2/cyclin E was subjected to helicase 
activity. The phosphorylated hMcm2-7 did not show any helicase activity, 
an observation supported by studies of Mcm4/6/7 complex (Ishimi et al., 
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2000a; Ishimi et al., 2000b; kudoh et al., 2006). Recently it has been proved 
that Mcm2-7 helicase loading was inhibited by CDK (Chen and Bell, 2011). 
 
These results suggest that one of the roles of phosphorylation by the cyclin-
dependent kinase is to inactivate the DNA helicase activity of the hMcm2-7 
complex that is probably involved in DNA replication in vivo. Based on 
these findings, it is considered that phosphorylated regions play a role in the 
interaction with DNA during DNA helicase action, and the phosphorylation 
of hMcm2-7 at specific sites by the cyclin-dependent kinase perturbs the 
interaction to inactivate the DNA helicase activity of the hMcm2-7 complex. 
This finding proves that Mcm proteins are substrate of the cyclin-dependent 
kinases. 
 
A few positive controls were missing in the helicase assays of 
phosphorylated hMcm2-7. It would have been very informative to the results 
as a whole with more positive controls on it. 
 
A number of sites of phosphorylation are already known on Mcm2, Mcm3 
and Mcm4 subunits (Ishimi et al., 2000; Montagnoli et al., 2006; Li et al., 
2011) that seem to regulate the function of Mcm complex. Further to this 
finding it is important to find out all the phosphorylation sites on hMcm2-7 
complex and determine which sites are playing a role in the inhibition of 
hMcm2-7 complex helicase activity. It could further indicate whethet any 
sites are lethal for hMcm2-7 helicase activity. 
 
Helicase related activity assays could have been performed with the hMcm2-
7 complex including ATP hydrolysis, DNA binding assays and processivity 
assays. ATP hydrolysis is assessed in the presence and absence of closed 
circular DNA templates using α[32P]ATP and then separating the hydrolysis 
product by thin layer chromatography. DNA binding assays can be carried 
out using electrophoretic shift assay with an oligonuleotide substrate labelled 
with γ[32P]ATP in the presence  and  absence  of ATP.  A  processivity  
assay  can  be  performed  by  using  a substrate that covers a range of sizes 
of duplex  DNA.  All   these  above   mentioned    assays   are   quantified by  
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phosphorimaging (Jenkinson and Chong, 2006). 
 
6.5 M. maripaludis S2 Mcms 
 
M. maripaludis S2 is unique among other archaea as it contains four Mcm 
homologues. It has been suggested that multiple Mcms are functional in M. 
maripaludis (Walters and Chong 2010) compared to rest of the archaea 
where one Mcm is sufficient for replication (McGeoch and Bell, 2008; Bae 
et al., 2009). All four MMP Mcms were co-purified successfully. MMP 
McmA and MMP McmC were purified efficiently in a single affinity 
purification step with his-tag. MMP McmB and MMP McmD were purified 
by GST affinity purification where a number of lower molecular weight 
proteins were present. To get rid of low molecular weight proteins, an 
additional step of anion exchange chromatography was carried out. The 
western blot was carried out on the elution fractions of each of the Mcms 
that confirmed the presence of each of the Mcms although the western blots 
were performed without any controls, which would have more reliably 
confirmed the results. In this study further investigation of the role of each 
Mcm in helicase assays was carried out. Helicase assays performed on MMP 
McmA showed that this protein has robust in vitro helicase activity 
suggesting this Mcm is functional. Helicase assays performed on MMP 
McmB also demonstrated this Mcm is functional too as this Mcm has also 
showed protein dependent robust helicase activity in vitro. Helicase assays 
were carried out on MMP McmC and MMP McmD under the same 
conditions that were used to demonstrate the helicase activities of MMP 
McmA and MMP McmB, but neither of these Mcms showed any in vitro 
helicase activity. As the concentration of MMP McmD was very low and 
also it was not as pure as were the other Mcms, a firm conclusion cannot be 
drawn on that basis and MMP McmD purification needs to be optimized 
before performing these assays. Although it was very surprising that MMP 
McmC did not show any helicase activity as it contain all the necessary 
motif require for helicase activity and it is quite similar to MMP McmA and 
MMP McmB in sequence. One explanation might be a requirement for other 
proteins or cofactors for MMP McmC to show helicase activity as shown 
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previously that Cdc45 and GINS are necessary for Drosophila Mcm2-7 
DNA helicase function (Moyer et al., 2006). 
Furthermore MMP McmA was subjected to helicase activity assays under 
various conditions to optimize the measured activity. The most interesting 
finding identified was presence of glutamate increase the helicase activity 
while the chloride decreases the helicase activity. This result is somewhat 
consistent with the previous work (Bochman and Schwacha, 2008) where 
they have shown the presence of anions completely abolishes helicase 
activity. The data presented in this study clearly show that even in the 
presence of high salt hMcm2-7 complex still showed some helicase activity. 
In previously published results post translationally modified Mcm2-7 would 
have acted differently in the presence of anionic salts as the complex was 
expressed from yeast (Bochman and Schwacha, 2008) while hMcm2-7 
complex used in this study was purified from E.coli. 
 
6.6 Potential DNA kinases in archaea 
 
Very little is known about the mechanisms that control DNA replication in 
archaea. Archaea lack recognizable homologues of cyclin dependent kinases, 
cyclins, or the kinase Cdc7. MMP0004 and Mj1073 are hypothetical proteins 
and bioinformatics has assigned them as RIO-type kinases. RIO-type kinases 
are family of conserved proteins present from archaea to eukarya and their 
biological substrate is still not known. Structural predictions of MMP0004 
and Mj1073 were obtained from different online data servers and the model 
is based on trying to fit the protein sequence to the most related structure in 
the database. They all came up with similar structure that was based on the 
most homologous known protein of A. fulgidus RIO2 Kinase in protein 
database (LaRonde-LeBlanc and Wlodawer 2004). The crystal structure of 
A. fulgidus RIO2 Kinase has been solved and the predicted ribbon structure 
of MMP0004 and Mj1073 is very similar to A. fulgidus RIO2 Kinase 
structure. Clustal alignment has shown that there are a few conserved 
residues specific to RIO kinase along with a specific ATP binding pocket 
and kinase domains in predicted structures. MMP0004 and Mj1073 were 
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successfully cloned and purified from E.coli. The mass spectrometry 
confirmed the identity of the MMMP0004 protein. Purified MMP0004 was 
tested as possible kinase acting on MMP McmA as it was identified as a 
interacting partner of MMP McmA (Chong lab unpublished data). Results 
from kinase assays showed that there was not any phosphorylation by 
MMP0004 on MMP McmA. The possible explanation for MMP0004 not 
acting as a kinase may be due to requirement of other proteins or cofactors in 
assay. MMP McmA might not be a substrate for MMP0004 or MMP0004 
might not be an active kinase though its sequence contains RIO type kinase 
motifs. As the purification of MMP0004 and Mj1073 has been successful 
and the purification concentrations of both proteins are very good, both of 
these proteins can be use in future in studies to ascertain their roles. 
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Appendix 1 
 
 
Abbreviations: 
 
A260, A280  Absorbance measured a 260 nm or 280 nm 
AAA+   ATPases Associated with various cellular Activities 
Amp   Ampicillin 
APS   Ammonium persulfate 
ARS   Autonomously replicating sequences 
ATM    Ataxia Telangiectasia Mutated 
ATP   Adenosine triphosphate 
ATPase  ATP hydrolysis (activity or domain) 
ATR   ATM and Rad3 related 
AX   Anion exchange 
BLAST   Basic Local Alignment Search Tool 
BSA   Bovine Serum Albumin 
CDC   Cell Division Cycle 
Cdt   Cyclin dependent transcript 
CDKs   Cyclin Dependent Kinases 
CV   Column Volumn 
DDKs   Dbf4 Dependent kinases 
DIG   Digoxigenin 
dNTPs   Deoxynucleoside triphosphates 
DTT   Dithiothreitol 
DUE   DNA Unwinding Element 
e   Expect score 
ECL   Enhance Chemiluminescence 
EDTA   Ethylenediaminetetraacetic Acid 
EF   Elution Fraction 
EGTA   Ethylene Glycol Tetraacetic Acid 
EM   Electron Microscopy 
FPLC   Fast Protein Liquid Chromatography 
FRET   Fluorescene resonance energy transfer 
GF   Gel Filteration 
GINS   Go, Ichi, Nii, San 
GST    Glutathione S-Transferase 
HEPES  (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
HPLC   High Performance Liquid Chromatography 
H2i   Helix-2 insert 
his-tag   Histidine tag 
Hsp   Heat shock protein 
HTH   Helix Turn Helix 
IAA    Isoamyl Alcohol 
IBs   Inclusion Bodies 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
iTRAQ  Isobaric Tag for Relative and Absolute Quantitation 
Kd   Dissociation constant 
KDa   Killo Dalton 
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LB   Luria-Bertani medium 
LC-MS  Liquid Chromatography Mass Spectrometry 
LIC   Ligation Independent Cloning 
MALDI  Matrix-Assisted Laser Desorption/Ionization 
MASCOT  Multiple Alignment System developed by iCOT 
MCM   Minichromosme maintenance 
MCM3AP   Minichromocome Maintenance Acetylating Protein 
MES   2-(N-morpholino)ethanesulfonic acid 
Mj   Methanocaldococcus jannaschii 
MMP   Methanococcus maripaludi proteins 
M-OBP  Methanococcales Origin Binding Protein 
MS   Mass Spectrometry 
MS/MS  Tandem Mass Spectrometry 
MthMcm Methanothermobacter thermautotrophicus Mcm 
protein 
NCBI North Carolina Banking Institute 
Ni-NTA  Nickel-Nitrilotriacetic Acid 
OBP   Origin Binding Protein 
OD600   Optical Density measured at 600 nm 
ODNs   Oligodeoxynucleotides 
ORB   Origin Recognition Box 
ORC   Origin Recognition Complex 
ORF   Open Reading Frame 
Ori   Origin of DNA replication 
OriC   Bacterial origin of replication 
PDB   Protein database/Data Bank 
PFD   Process Flow Diagram 
PEG   Polyethylene Glycol 
PCR   Polymerase Chain Reaction 
PMSF   Phenylmethylsulphonyl Fluoride 
PNK   Polynucleotide Kinase 
PS1BH  Pre-sensor 1 beta-hairpin 
PVDF   Polyvinylidene Fluoride 
R-finger  Arginine finger 
RIO   Right Open Reading frame (yeast kinase gene) 
RPC   Replisome progression complex 
RNAi   RNA interference 
RT-PCR  Real-Time Polymerase Chain Reaction 
SDM   Site-Directed Mutagenesis 
SDS   Sodium Dodecyl Sulfate 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis 
SEC   Size Exclusion Chromatography 
S-layer   Surface layer 
SOC   Super Optimal Broth “catabolite repression” 
Spec   Spectinomycin 
SSB   Single-strand binding protein 
SSC   Saline Sodium Citrate buffer 
Sso Mcm  Sulfolobus solfataricus Mcm 
SV40   Simian Virus 40 
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TAE   Tris-Acetate EDTA 
Tag   SV40 large tumour antigen 
TBE   Tris Boric acid EDTA 
TE   Tris EDTA 
TEAB   Triethylammonium Bicarbonate 
TEMED  Tetramethylethylenediamine 
TOF   Time Of Flight 
TP   Total Protein 
Trx   Thioredoxin 
UB   Unbound 
UV   Ultra Violet 
wHTH   winged Helix Turn Helix 
WT    Wild Type 
w/v   weight/volume 
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Appendix 2 
 
List of chapter 3 primers 
 
Table A1: Primer sequences for SDM of hMcm 2-7 genes 
Primer 
Name 
Direction 
of 
Primer 
Sequence 5’ →3’ of Primer 
SDM 
hMcm2 
Forward GATTCCGCCATGGTATCCTGGTACCCGGG 
SDM 
hMcm2 
Reverse  CCCGGGTACCAGGATACCATGGCGGAATC 
SDM 
hMcm3 
Forward CGGTACCCGCCATGAATTTCGGATCCTGGTACC 
SDM 
hMcm3 
Reverse  GGTACCAGGATCCGAAATTCATGGCGGGTACCG 
SDM 
hMcm4 
Forward GCCGGGGACGACATGAAATTCGGATCCTGG 
SDM 
hMcm4 
Reverse  CCAGGATCCGAATTTCATGTCGTCCCCGGC 
SDM 
hMcm5 
Forward CGAATCCCGACATGAATTTCGGATCCTGGTACC 
SDM 
hMcm5 
Reverse  GGTACCAGGATCCGAAATTCATGTCGGGATTCG 
SDM 
hMcm6 
Forward CCGCGAGGTCCATGAATTTCGGATCCTGGTACC 
SDM 
hMcm6 
Reverse  GGTACCAGGATCCGAAATTCATGGACCTCGCGG 
SDM 
hMcm7 
Forward CCTTCAGTGCCATGAATTTCGGATCCTGGTACC 
SDM 
hMcm7 
Reverse  GGTACCAGGATCCGAAATTCATGGCACTGAAGG 
Bold letters indicate start and stop codons. 
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Table A2: Primer sequences for LIC of hMcm 2-7 genes 
 
Primer 
Name 
Direction 
of Primer 
Sequence 5’ →3’ of Primer 
LIC 
hMcm2 
Forward GCGGGCCCGGCCTCCATGGCGGAATCAT
CGGAATCCTTCACC 
LIC 
hMcm2 
Reverse  GAGGAGAAGCCCGGTCAGAACTGCTGCA
GGATCATTTTCC 
LIC 
hMcm3 
Forward GCGGGCCCGGCCTTCATGGCGGGTACCG
TGGTGCTGGAC 
LIC 
hMcm3 
Reverse  GAGGAGAAGCCCGGTCAGATGAGGAAGA
TGATGCCCTCAG 
LIC 
hMcm4 
Forward GCGGGCCCGGCCTTCATGTCGTCCCCGGC
GTCGACCCC 
LIC 
hMcm4 
Reverse  GAGGAGAAGCCCGGTCAGAGCAAGCGCA
CGGTCTTCCC 
LIC 
hMcm5 
Forward GACGACGACAAGATGTCGGGATTCGACG
ATCCTGGC 
LIC 
hMcm5 
Reverse  CGCGGGCGGCCGTCACTTGAGGCGGTAG
AGAACCTTGC 
LIC 
hMcm6 
Forward GACGACGACAAGATGGACCTCGCGGCGG
CAGCGG  
LIC 
hMcm6 
Reverse  CGCGGGCGGCCGTCAATCTTCGAGCAAG
TAGTTAGGG 
LIC 
hMcm7 
Forward GACGACGACAAGATGGCACTGAAGGACT
ACGCGCTAG 
LIC 
hMcm7 
Reverse  CGCGGGCGGCCGTCAGACAAAAGTGATC
CGTGTCCGGG 
 
Bold letters indicate start and stop codons. 
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Table A3: Primer sequence of helicase substrate 
 
Primer 
Name 
Sequence 5’ →3’ of Primer 
HS2 (TTTG)8CCGACGTGCCAGGCCGACGCGTCCC 
HS1 GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCA
GGCACCCGATGGC(GTTT)6 
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List of chapter 5 Primers 
 
Table A4: Primer sequences for cloning of MMP0004 and Mj1073 
 
Primer 
Name 
Direction of 
Primer 
Sequence 5’ →3’ of Primer 
MMP0004 Forward TTCAATGGATCCAATGGAAGATAACG
ACTGGAAATTG 
MMP0004 Reverse  AAACTCGAGTTAAATTTCGCTAGTTA
TATCTCCAATAAC 
Mj1073 Forward AGAGGATCCAATGAGACATCATGAG
TG 
Mj1073 Reverse  CCACTCGAGTTATTTAGTTATATACTC
AAAGATTTT 
 
 
Bold letters indicate start and stop codons, while underline letters indicate 
restrictions sites. 
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